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INTRODUCTION 
Bacterial populations rarely encounter ideal growth conditions and spend most 
of their existence accommodating some kind of stress. Nutrient limitation, 
hazardous chemicals, and hostile neighbors are all part of bacterial life. Bacteria 
have evolved many stress response pathways to cope with different harsh en-
vironments. The genetic units termed toxin-antitoxin systems are often seen as 
parasitic and selfish, however, toxin-antitoxin systems also seem to be recruited 
into stress response pathways in some cases. These addictive modules encode 
for an autotoxic protein and an antitoxin that inhibits the activity of the toxin. 
Because antitoxins are much more unstable than toxins, the loss of the toxin-
antitoxin module results in active toxins that inhibit cell growth. Different 
studies associate toxin-antitoxin systems with abortive bacteriophage infections, 
growth regulation during stress, antibiotic tolerant persister cells, and bacterial 
virulence. Thus, studying toxin-antitoxin systems is likely to be beneficial for 
understanding and combating bacterial infections. 
The functions of toxin-antitoxin systems that are associated with stress 
response are mostly thought to be straightforward: they downregulate bacterial 
growth during stress. However, some toxin-antitoxin systems are reported to act 
in more subtle ways and regulate the expression of specific genes. An endo-
ribonuclease toxin of Escherichia coli, MazF, is hypothesized to be a center-
piece of such a specific network. Recent publications claim that MazF comple-
tely reprograms the translational machinery of E. coli. MazF has been reported 
to remove a 43 nucleotide fragment from the 3’ end of 16S rRNA in mature 
ribosomes during various stresses [1]. It has been postulated that these modified 
ribosomes specifically translate 5´truncated mRNAs [1,2]. Upon activation, 
MazF is hypothesized to degrade the bulk of the transcripts, but cleave the 
mRNAs of around 300 genes only in 5’ UTR, which are then specifically 
translated by the truncated ribosomes [2]. We have seen the emergence of 
several large rRNA cleavage fragments in response to MazF and MqsR expres-
sion in E. coli, thus raising the possibility that these toxins also regulate growth 
via ribosome degradation. Alternatively, these toxins could only cleave pre-
cursor rRNAs and disturb ribosome biogenesis. 
This dissertation largely focuses on studying the cleavage profiles of MazF 
and MqsR of E. coli. We mapped MazF and MqsR cleavage sites in rRNA and 
mRNA with an aim to clarify the function of these toxins. We also tested the 
intriguing hypothesis that toxins could activate non-cognate TA systems. 
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1. REVIEW OF THE LITERATURE 
Bacterial toxin-antitoxin (TA) systems are small genetic modules that encode a 
toxic protein, which inhibits the growth of the bacteria producing it, and an anti-
dote, which neutralizes the toxin [3–7]. Antitoxins are usually more labile than 
toxins and need to be constantly produced to keep the toxins at bay [6,8,9]. The 
toxins become free to act when the antitoxin to toxin ratio drops below a critical 
level. TA systems were first discovered as plasmid maintenance units [10,11], 
but soon afterwards many more were discovered in chromosomal DNA [12,13]. 
Currently, thousands of putative TA systems have been identified in a wide 
range of bacteria and archaea (http://bioinfo-mml.sjtu.edu.cn/TADB2/)[14]. 
Some bacteria have dozens upon dozens of TA system, e.g. Mycobacterium 
tuberculosis contains at least 88 of these small genetic modules [15]. Despite 
their abundance, the role of chromosomal TA systems in bacterial physiology 
remains elusive. Some hypotheses treat TA systems only as selfish genes, 
whose sole function is to propagate themselves [16].  On the other hand, several 
studies view TA systems playing a role in stress response, antibiotic tolerance, 
and virulence [7,17,18].  
 
 
1.1. Classes of toxin-antitoxin systems and  
their regulatory architecture 
TA systems are grouped into six types, based on the nature and inhibitory 
mechanism of the antitoxin  (Figure 1) [19]. In types I and III, the antitoxins are 
RNAs, while the remaining TA systems all have protein antitoxins. Type I anti-
toxin is an antisense RNA complementary to the toxin mRNA, which obstructs 
the formation of the initiation complex and/or destabilizes the toxin transcript. 
Types II and III antitoxins inhibit toxins by direct interaction. Type IV anti-
toxins negate the activity of the toxin by stabilizing its target. The antitoxin of 
type V TA system cleaves toxin mRNA. Type VI antitoxin promotes the degra-
dation of the toxin. An overview of the mechanisms and more well studied 
members of various types of TA systems is presented below. 
 
 
1.1.1. Type I toxin-antitoxin systems 
Type I antitoxins 
Type I antitoxins are non-coding RNAs (ncRNA) that bind to toxin mRNAs and 
inhibit the translational initiation and/or promote mRNA degradation (Figure 1) 
[20–22]. Antitoxin RNAs are unstable and need to be constantly produced to 
obstruct the translation of toxin-encoding transcripts [8,22]. Most type I anti-
toxins have an overlap with toxin gene, but some, like IstR-1 of tisB/istr1 
system of E. coli, are located away from the toxin, and have more limited 
complementarity [22,23]. These two groups of antitoxins are classified as cis- or 
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trans-acting, respectively. In addition to antitoxin-mediated control, the toxin 
mRNAs are usually highly structured and often mask the Shine-Dalgarno 
sequence from ribosomes thereby avoiding toxin translation even without 
binding of the antitoxin [20,21]. Strong secondary structure also stabilizes the 
toxin mRNA making it more stable than the antitoxin RNA [24]. The unpro-
cessed toxin mRNA has been demonstrated in several cases to be both un-
translatable and inaccessible to antitoxins. Processing by nucleases is required 
to “activate” such mRNAs [20,21]. The toxin mRNAs of cis- and trans-acting 
antitoxins are activated differently: the former are processed in 3’-end and latter 
in 5’-end [20,21]. The regulation of toxin activity has been best studied for 
hok/sok TA system of E. coli R1 plasmid and tisB/istR1 TA system of E. coli 
(reviewed by Berghoff and Wagner [21]). hok/sok represents a TA system with 
a cis-acting antitoxin, while tisB/istR1 has a trans-acting antitoxin. Translation 
of hok is regulated by mok gene, which is located on the same transcript 
upstream of hok. It overlaps with hok and encodes a protein with an unknown 
function. RNase II and polyribonucleotide nucleotidyltransferase trim 39 
nucleotides from the 3’ end of mok/hok transcript, which induces structural 
rearrangements in toxin mRNA. The ribosomal binding site of hok gene 
remains sequestered, but mok becomes translatable. Synthesis of Mok opens up 
the ribosomal binding site of hok. The sok antitoxin inhibits the translation of 
mok and thus indirectly also shuts down the production of the toxin. RNase III 
cleaves the antitoxin/toxin mRNA duplex, thereby inactivating it [8]. tisB 
mRNA is cleaved by an unknown nuclease that removes 42 nucleotides from its 
5’ end. This exposes the ribosomal standby site and allows for ribosomal pre-
loading. However, usually this is precluded because antitoxin IstR1 masks the 
ribosomal standby site and RNase III cleaves the toxin mRNA/antitoxin 
complex [23]. 
Other strategies for stalling toxin translation have also been reported (re-
viewed by Masachis and Darfeuille [20]). txpA and yonT toxin transcripts have 
been speculated to have longer translational initiation times, caused by strong 
complementarity between their Shine-Dalgarno sequence and the 3’ end of 16S 
rRNA [25,26]. Usage of rare start codons, such as GUG in yonT, is another 
feasible stalling mechanism.  The ribosomal binding site in yonT mRNA is not 
masked [27], giving credibility to the existence of alternative initiation stalling 
mechanisms. 
 
Type I toxins 
Most type I toxins are short (less than 60 amino acids), hydrophobic proteins 
that contain a putative α-helical trans-membrane domain [22]. Despite the 
similarities, the mechanisms of action seem to differ. Hok [28] and TisB [29,30] 
toxins of E. coli form pores that result in depolarization of the cell membrane 
and decreased ATP production. Overexpression of such toxins leads to cell 
death, but it is likely that lethal doses of toxin are not reached under physio-
logically relevant conditions [22,29,31]. For example, Gerdes et al. argue that a 
feedback loop ensures safe levels of HokB in E. coli [31]. In short, membrane 
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bound RNase E constantly degrades the SokB antitoxin, but sufficient amounts 
of SokB remain in good growth conditions to neutralize the toxin. Stressful 
conditions increase hokB transcription beyond the level where existing SokB 
levels are able to handle. HokB then depolarizes the membrane and causes 
RNase E to detach, which decreases its activity and results in higher antitoxin 
levels [31]. A simpler loop may be enough: lower energy levels caused by 
toxins result in slower toxin translation. 
 
Figure 1. Different types of toxin-antitoxin systems. In type I TA systems the antitoxin 
is an antisense RNA which neutralizes toxins by binding to its mRNA and masking the 
ribosome binding site and/or promoting the degradation of toxin mRNA. Type II 
antitoxins are proteins which inactivate toxins by direct interaction. Type II antitoxins, 
as well as TA complexes, often also repress the toxin-antitoxin promoter. Type III 
toxins are RNAs which inhibit toxins by direct interaction. In type IV TA systems the 
antitoxin stabilizes the toxin target. Type V antitoxins are RNases which specifically 
degrade toxin mRNAs. Type VI TA systems are adapter proteins which promote the 
degradation of toxins. 
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The Fst/Ldr family of toxins cause abnormal nucleoid condensation (reviewed 
by Brielle et al. [22]). Overexpression of Fst toxin encoded by the RNAI/RNAII 
TA system of Enterococcus faecalis pAD1 plasmid leads to nucleoid 
condensation in E. coli, B. subtilis, E. faecalis, and S. aureus [32–35]. Nucleoid 
condensation, in turn, causes defects in cell division and growth [33]. Another 
member of the Fst/Ldr family, the LdrD toxin of E. coli, also causes nucleoid 
condensation while overexpressed in its parent organism [36]. On the other 
hand, transient production of its homolog, the LdrA of E. coli, was instead 
shown to inhibit ATP synthesis [37]. Thus, it is possible that this nucleoid 
condensation results from a damaged energy production system, and the toxins 
act much like Hok and TisB. 
The BsrG toxin of SPβ prophage in B. subtilis disturbs the envelope bio-
synthesis when overexpressed and causes invagination of the cytoplasmic 
membrane. Prolonged BsrG production leads to altered cell morphology, 
abnormal cell division sites, and cell lysis [38]. 
Only two type I toxins, SymE and RalR, are known to localize outside of the 
membrane [22]. Both of these are cytosolic nucleases, although SymE cleaves 
RNA [39], and RalR DNA [40]. Upon overexpression, the SymE of E. coli 
strongly inhibits protein synthesis and the ability to form colonies [39]. 
Although SymE co-purifies with ribosomes, which suggests ribosome depen-
dant activity, its expression also reduces the levels of non-coding RNAs [39]. 
Paradoxically, SymE belongs to the AbrB superfamily, which contains many 
type II antitoxins that inhibit endoribonuclease toxins [41]. In E. coli the 
ralR/ralA TA system forms part of the rac prophage. RalR overproduction 
results in filamentous cells and growth inhibition. In vitro experiments show 
strong non-specific endodesoxiribonuclease activity against both methylated 
and non-methylated DNA, and fail to detect RNase activity [40].  
 
 
1.1.2. Type II toxin-antitoxin systems 
Type II antitoxins 
Type II TA systems are the most prevalent and best studied TA systems [6,19]. 
Type II antitoxins are small proteins that inactivate toxins by direct interaction 
(Figure 1) [6,19]. Their toxin and antitoxins form complexes where the anti-
toxin blocks the active site of the toxin or induces conformational changes that 
render the toxin inoperative (reviewed by Yamaguchi et al. [3] and by Chan et 
al. [42]). Also, in some ribosome dependant-ribonuclease toxins, the antitoxin 
has been shown to act by hindering the interactions between toxins and ribo-
somes [43,44]. Blocking the active sites seems to be the most common mecha-
nism of toxin neutralization. In type II TA systems, the toxin and antitoxin 
genes usually form an operon where the antitoxin is located upstream. Still, 
there are several exceptions to this rule such as the mqsRA, higBA, and rnlBA 
TA systems of E. coli where the toxin gene precedes the antitoxin [45–48]. 
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The different stability of toxin and antitoxin proteins is speculated to be the 
key to activating type II TA systems [6,7,19,42]. Most type II antitoxins have an 
unstructured toxin binding domain which makes them highly susceptible to 
degradation by proteases such as Lon, ClpXP, and/or ClpAP [3,6,7,19,49]. The 
antitoxins are stable in the toxin-antitoxin complex where the previously dis-
ordered toxin binding domain becomes ordered [3]. Toxins, on the other hand, 
are also stable in free form [6,19]. Assuming that TA complexes dissociate, the 
antitoxins need to be constantly produced to neutralize the toxins. Without an 
influx of new antitoxins, the toxins eventually outlive their inhibitors. By this 
theory, toxins are freed when protein production is slowed down, e.g. during 
various stresses. A more direct way to stop antitoxin production and free the 
toxins would be the loss of TA modules [16], for example, via the loss of a 
plasmid containing TA systems. 
TA systems are hypothesized to avoid accidental toxin activity by ensuring 
an excess of antitoxins. One way to achieve this is thought to be through trans-
lational coupling. Because the genes of type II TA systems often overlap or are 
only few nucleotides apart [3,42], they are speculated to be translationally 
coupled [12]. Assuming translational coupling, the antitoxins, which are usually 
the first gene in the TA operon, are produced before the toxins. Such a mecha-
nism would help to reduce stochastic increase in the toxin/antitoxin ratio. Pre-
valence of this strategy requires further study, however, because to our know-
ledge the kis/kid TA system on the R1 plasmid is currently the only TA system 
with experimental evidence that supports translational coupling [50]. A recent 
study that analyses ribosomal profiling and RNA sequencing data from ten type 
II TA systems within E. coli concluded that the translational initiation rate for 
most antitoxins is higher than for their cognate toxins [51]. The higher antitoxin 
production in two TA systems, dinJ-yafQ, and yafNO, is speculated to be 
secured at the transcriptional or post-transcriptional level, as many of the toxin 
transcripts are truncated [51]. Some type II TA systems with an upstream toxin 
gene, e.g. rnlBA of E. coli [52], have a separate promoter for antitoxin pro-
duction located inside the transcript region that encodes the toxin. Such TA 
systems can produce a polycistronic TA transcript and also a transcript that 
contains only the antitoxin gene. The excess of antitoxin in the rnlBA of E. coli 
was reported to be controlled through higher levels of antitoxin mRNA [51]. 
Intriguingly, the translation rates of the RnlB toxin and RnlA antitoxin are 
similar, thus making differential transcriptional regulation likely the primary 
way of guaranteeing an excess of antitoxin in this system [51]. 
Antitoxins also act as the repressors of TA operons [6,19,42]. Generally, the 
C-terminal domain of the antitoxin binds to toxins and the N-terminal domain 
interacts with DNA [6,19,42]. Antitoxins bind to TA promoters also while in 
complex with the toxin [42]. The repression by the TA complex is usually 
stronger than by free antitoxin [42]. Such autorepression results in smaller meta-
bolic burden for the bacteria, but still keeps a pool of toxins ready for activation 
[7]. Degradation of antitoxins leads to transcriptional derepression of the TA 
operon and consequently increases the amount of TA mRNA. After the stress is 
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relieved and translational activity increases, rapid antitoxin production can 
quickly abolish the toxin activity and repress the operon. 
Some type II TA systems link the cellular toxin/antitoxin ratio with their 
promoter activity by a mechanism termed conditional cooperativity (reviewed 
by Harms et al. [7], by Page and Peti [19], and by Chan et al. [42]). The TA 
complexes of these TA systems have different stoichiometry based on the 
cellular toxin/antitoxin ratio. Complexes formed in an excess of antitoxin act as 
strong repressors, but as the toxin/antitoxin ratio increases, complexes with low 
affinity to the promoter start to form. For example, in the relBE system the 
RelE:RelB2 heterotrimers (i.e. 1:2 toxin/antitoxin ratio) bind to the promoter 
with strong affinity. However, a 1:1 toxin/antitoxin ratio leads mostly to the 
formation of RelE2:RelB2 heterotetramers which bind weakly to the promoter 
[19,42]. The benefits of conditional cooperativity are not clear, but several 
different models have been proposed, as summarised by Harms et al. [7]. It may 
be another form of insurance against accidental toxin activation: if the antitoxin 
levels drop because of intrinsic fluctuations, more TA transcripts will be 
synthesised and more antitoxins produced. Conditional cooperativity can also 
amplify the activation of TA systems during stress, as transcription gets dere-
pressed sharply to produce more toxin-antitoxin mRNA. Finally, conditional 
cooperativity may generate bistability in the population and act as a sharp 
switch from a growing to a dormant bacterial population. 
Several type II TA systems consist of three components (reviewed by Chan 
et al. [42]) and these extra proteins are involved in either transcriptional 
autorepression of the TA operon or inactivation of toxins. In the ω-ε-ζ TA of 
Streptococcus pyogenes, the ω protein acts as the sole repressor of the toxin-
antitoxin operon [53], while in the paaRAE TA of E. coli O157:H7 the extra 
component PaaR enhances the repression [54]. PasC of pasABC TA from 
Acidithiobacillus ferroxidans strengthens the ability of the antitoxin to 
inactivate the toxin [55]. 
 
Type II toxins 
Type II toxins have a diverse set of targets and mechanisms of action (Figure 2) 
[6,7,56]. Toxins attack translation, replication or cell wall synthesis. Still, most 
type II toxins inhibit protein production [6,7,56]. More prominent examples of 
mechanisms by which type II toxins inhibit the cell growth are presented below. 
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Figure 2. Targets of selected toxins. Red lines connect toxins with their molecular 
targets or show the molecular function, which is being inhibited. Destructive actions of 
toxins are shown with arrow head ends and inhibitory and/or corruptive actions of 
toxins with blunt ends. Based on Harms et al. 2018 [7].  
 
 
Endoribonuclease toxins of type II TA systems 
The most common mechanism of action among type II toxins (and toxins of all 
TA systems in general) is endoribonuclease activity. Some toxins bind to ribo-
somes and act on mRNAs during translation. Others cleave RNA indepen-
dently, usually having specificity to certain sequences [5–7]. Ribosome in-
dependent endoribonucleases mostly cleave single stranded unprotected RNA. 
They have been classically viewed as degraders of mRNA [3], however, recent 
studies demonstrate their ability to cleave the rRNA, tRNA, and ncRNA as well 
[5]. 
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Ribosome-dependent endoribonucleases 
Most RelE family (RelE, YoeB, YafQ, and HigB toxins) and YafO family 
toxins cleave mRNA in a ribosome-dependent manner (reviewed by Yamaguchi 
and Inouye [57]). RelE of E. coli binds to the ribosomal A site where it interacts 
with 16S rRNA and cleaves codons between the second and third nucleotide 
[58,59]. The UAG stop codon is the main target of RelE, but other codons are 
also cleaved [58]. YoeB of E. coli, binds to the 50S subunit in ribosomal A site 
and cleaves primarily right after the start codon [60]. HigB of Proteus vulgaris 
and YafQ of E. coli cleave preferentially at AAA lysine codon [61,62]. YafO of 
E. coli binds to the 50S subunit and cleaves mRNA 11-13 nucleotides down-
stream of the start codon [63]. The GraT toxin of Pseudomonas putida’s graTA 
system is a HigB homolog [64], which cleaves codons with an adenine at the 
second position [44]. One of the main effects of GraT is the inhibition of ribo-
somal biogenesis [65,66]. The overexpression of several ribosome-dependent 
ribonuclease toxins have been demonstrated to effectively shut down translation 
and lead to growth inhibition [57]. 
 
Ribosome-independent endoribonucleases 
MazF of E. coli was the first toxin shown to have sequence specific ribo-
nuclease activity [67]. MazF cleaves the ˇACA sequence, whereˇ indicates the 
cleavage position, leaving 3’-cyclic P and 5’-OH ends [2,68]. Recently a 
context bias for nucleotides surrounding ACA was reported, opening up the 
possibility of the preferred recognition sequence being longer [69]. Crystallo-
graphy experiments show that the nucleotides at both sides of ACA sequences 
have to be single stranded to interact with MazF [70]. Initially, MazF of E. coli 
was thought to only degrade mRNA, however, recent studies show that it is also 
capable of cleaving rRNA [1,69,71]. Vesper et al. report cleavage of 16S rRNA 
at 3’-end in ribosomes [1]. Culviner and Laub on the other hand detected 
widespread cleavage in rRNA precursors [69]. 
The MazF family has many members across the bacterial and archaeal phyla. 
The MazF cleavage recognition sequences vary from three to seven bases [5]. 
MazF of Haloquadratum walsbyi currently holds the record for the longest 
verified cleavage recognition sequence with seven nucleotide UUˇACUCA 
[72]. Specific seven nucleotide sequence has a one in 16,384 chance of random 
occurrence. Only 7% of open reading frames (ORF-s) in H. walsbyi contain the 
UUACUCA sequence [72]. Such toxins must target transcripts of vital im-
portance to inhibit growth. rRNA would satisfy this requirement, but has not 
been shown to be cleaved by MazF of H. walsbyi [72]. 
Two of nine Mycobacterium tuberculosis’s MazF family members, MazF-
mt3 and MazF-mt6, have been shown to cleave rRNA [73,74]. Both toxins 
cleave a conserved UUCCU sequence in 23S rRNA at helix 70  [73,74], which 
is essential for ribosome assembly and interactions with the ribosome recycling 
factor and tRNA [5]. Cleavage by MazF-mt3 was initially detected in E. coli 
after transient toxin expression using RNA sequencing and verified for 23S 
rRNA of M. tuberculosis using an in vitro cleavage assay with total RNA [74]. 
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Ectopic expression of MazF-mt6 results in the cleavage of 23S rRNA in M. 
smegmatis and E. coli, the cleavage of 23S rRNA in M. tuberculosis was 
demonstrated using an in vitro total RNA cleavage assay [73]. MazF-mt6 was 
reported to cleave 23S rRNA in the 50S ribosomal subunits of E. coli using a cell-
free translation system (70S was dissociated by a low Mg2+ concentration), how-
ever, the experiments did not detect cleavage in 70S subunits [74]. MazF-mt3 also 
cleaves, in addition to 23S rRNA, the anti-Shine-Dalgarno sequence of E. coli 16S 
rRNA, however, the cleavage seems to mostly happen in precursor rRNA as evi-
denced from very low in vivo cleavage of rRNA in assembled 70S ribosomes [74]. 
MazF-mt9 of M. tuberculosis is currently the only MazF family toxin known 
to cleave tRNAs. MazF-mt9 cleaves the D-loop of tRNAPro14 and the anticodon 
loop of tRNALys43. Both sites have the UUˇU recognition sequence in a single 
stranded form [75]. tRNA is also the substrate for several VapC family toxins 
which act as metal ion dependent PIN (PilT N-terminus) domain ribonucleases 
[76]. VapC toxins have high substrate specificity and several of them recognize 
structure beyond the nucleotide sequence [77–80]. VapC toxins of Shigella 
flexneri 2a, Salmonella enterica and Leptospira interrogan cleave the initiator 
tRNAfmet in the anticodon loop [77,78]. M. tuberculosis has 48 vapBC TA 
systems and several of these toxins have been demonstrated to cleave tRNA in 
the anticodon loop [79,80]. VapC-mt20 and VapC-mt26 of M. tuberculosis 
were shown to cleave Sarcin-Ricin loop of 23S rRNA, cleavage by VapC-mt26 
was demonstrated in 70S ribosomes using an in vitro cleavage assay [80,81]. 
Although most of the RelE family toxins are ribosome-dependant endoribo-
nucleases, some of them, including MqsR and YhaV, act independently of the 
ribosome [5]. MqsR of E. coli cleaves GˇCN sequences, with GˇCU and GˇCA 
being primary recognition motives [47,82]. In vitro RNA digestion experiments 
have shown that YhaV of E. coli cleaves both mRNA and rRNA [83]. 
Recognition sequence for YhaV has not been identified. 
The cleavage of regulatory non-coding RNAs are less studied. MazF of E. 
coli cleaves ACA in a central loop of 6S RNA [69] and the HicA toxin of E. 
coli cleaves tmRNA at two AˇAAC sites [84]. Ribosome-independent endo-
ribonucleases can, in principle, cleave all ncRNA which have a recognition 
sequence in single stranded portion of the RNA, or the necessary folds for 
toxins that cleave structured RNA. 
In conclusion, some ribosome-independent endoribonuclease toxins can 
cleave a wide variety of unstructured transcripts while others target only highly 
specific structures [5]. The cleavage of mRNA, rRNA, and/or tRNA can all lead 
to growth inhibition. 
 
Toxic kinases 
HipA of E. coli’s hipBA system inactivates glutamyl-tRNA synthetase by 
phosphorylation of serine 239 [85,86]. The uncharged tRNAGlu pool stalls the 
translation and induces the stringent response [85,86]. PhD toxin of phage P1 
phosphorylates translation elongation factor Tu 1 (EF-Tu) at Thr382, which con-
sequently loses its ability to bind tRNAs [87]. PezT of Streptococcus pneumo-
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niae, a member of the Zeta toxin family, inhibits peptidoglycan synthesis by 
phosphorylating uridine diphosphate-N-acetylglucosamine. MurA, an essential 
protein for peptidoglycan synthesis, is inhibited by phosphorylated uridine 
diphosphate-N-acetylglucosamine. Overexpression of PezT in fast-growing E. 
coli culture leads to cell lysis [88]. 
 
Inhibitors of ribosome association 
RatA toxin of E. coli inhibits translation by binding to 50S subunits and inter-
fering with 70S ribosome association [89]. RatA only inhibits the formation of 
new 70S, but is not capable of dissociating existing 70S ribosomes. Overpro-
duction of RatA inhibits growth and translation less efficiently than ribo-
nuclease toxins. Although genomic organisation suggests a TA system, the 
hypothetical antitoxin has not been observed to inactivate the toxin or bind to it. 
 
Acetyltransferases of aminoacyl tRNAs 
A subset of toxins that are homologous to Gcn5N-acetyltransferases inactivate 
charged tRNAs by acetylation [90,91]. TacT of Salmonella typhimurium acety-
lates primary amino groups of amino acids on charged tRNAs. Amino acids with 
acetylated amine groups likely do not form peptide bonds and lead to translational 
shut down. The specificity of TacT of S. typhimurium is unknown, however, 
authors speculate it to be broad [90]. Overexpressing TacT of S. typhimurium 
during lag phase prolongs it by several hours, yet growth remains unaffected if 
TacT is expressed in exponentially growing culture [90]. This indicates that TacT 
of S. typhimurium does not act as a general growth inhibitor, and may instead 
have evolved to strengthen growth stasis. In contrast with TacT, the acetyl-
transferase toxin AtaT of E. coli O157:H7 is highly specific to charged initiator 
tRNAfMet and inhibits the formation of the initiation complex [91]. Overexpres-
sion of AtaT effectively inhibits the colony formation ability of E. coli [91]. 
 
DNA replication inhibitors 
CcdB of F plasmid and ParE of RK2 plasmid inhibit DNA replication by cor-
rupting DNA gyrase. As with quinolone antibiotics, CcdB and ParE freeze the 
gyrase in an open complex with cleaved DNA, denying the re-ligation step [92–
94]. This results in double stranded DNA breaks, filamentous cells, inhibited 
cell growth, and eventually cell death [93,95,96]. Although similar in action, 
CcdB and ParE do not share structural similarity and likely interact with gyrase 
through different mechanisms. This is supported by the finding that CcdB 
resistance mutation in gyrA does not protect against ParE of RK-2 plasmid or 
ParE2 of Vibrio cholera [95,97]. 
The toxins of the FicT family inhibit replication more mildly, without in-
ducing double stranded breaks in the DNA [98]. FicT toxins inactivate DNA 
gyrase and topoisomerase IV by AMPylating their ATP binding domains. 
Different FicT toxins from various organisms have been shown to inactivate the 
gyrase and topoisomerase IV of E. coli. Overexpression of FicT leads to fila-
ments and growth inhibition due to DNA knotting, catenation, and relaxation. 
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DNA-targeting toxins 
DarT of Thermus aquaticus ADP-ribosylates single stranded DNA [99]. Bro-
modeoxyuridine incorporation assay shows that DNA replication in E. coli be-
comes inhibited while overexpressing DarT. The antitoxin DarG seems to 
mainly counteract the toxin with its de-ADP-ribosylation activity, however, 
inhibition of toxin by direct interaction also seems to occur [99]. It is thus 
debatable if darTG belongs to type II TA or constitutes a new class, where the 
antitoxin acts by reversing toxin-generated modifications. 
 
 
1.1.3. Type III toxin-antitoxin systems 
Toxins of type III TA systems are inhibited by RNA antitoxins, but unlike type 
I, the RNA interacts directly with the toxic protein (Figure 1)(reviewed by 
Goeders et al. [9]). Based on toxin sequence similarity, the type III TA systems 
fall into three sub families: toxIN, cptIN, and tenpIN [100]. Most information 
about type III TA comes from studying the toxIN sub family [9]. As with type II 
modules, the toxin and antitoxin genes are located in the same bicistronic 
operon, where the antitoxin gene precedes the toxin. A rho-independent termi-
nator is situated between the antitoxin and toxin gene, possibly ensuring a high 
antitoxin to toxin ratio. The excess of antitoxin is also promoted at post-
transcriptional levels. The antitoxin gene encodes an ncRNA composed of short 
repeats, which is cut to monomers by the cognate toxin. These monomers in-
hibit the toxin by binding to their active sites. Thus, a single antitoxin transcript 
results in several toxin-neutralizing RNAs. The number of repeats varies, 
however, their length tends to be similar within one toxin sub-family [9,100]. 
Similar to type I and II TA systems, the type III antitoxins are less stable than 
their cognate toxins [101]. 
Antitoxin RNA monomers form a central pseudoknot structure and bind 
toxins with flanking tails and parts of the pseudoknot [9]. The crystal structures 
of toxIN family members that have been resolved so far reveal  heterohexameric 
toxin-antitoxin complexes [102,103]. The products of cptIN of Eubacterium 
rectale, on the other hand, form heterotetrameric toxin-antitoxin complexes 
[104]. A recent report proposes that only a small portion of ToxN toxins stay in 
heterohexameric complexes and these toxins are mostly engaged in processing 
the antitoxin precursors [105]. 
Type III toxins are sequence-specific endoribonucleases that are structurally 
similar to MazF family toxins  [9]. ToxN family members preferentially cleave 
adenine-rich sequences: ToxN of Pectobacterium atrosepticum plasmid 
pECA1039 cleaves at AAˇAU, ToxN of Bacillus thuringiensis plasmid  pAW63 
cleaves at AˇAAAA and AbiQ of Lactococcus lactis plasmid pSRQ900 cleaves 
at AˇAAA [103,106]. Overexpressing toxins in the ToxN family leads to growth 
inhibition [101,103,106]. As with most type II endoribonuclease toxins, mRNA 
is speculated to be the main target for type III toxins [9]. 
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1.1.4. Type IV toxin-antitoxin systems 
Antitoxins of type IV TA systems are proteins that negate the activity of the 
toxin by stabilizing the target (Figure 1). There is no direct contact between the 
toxins and antitoxins of type IV TA systems. The gene organization of type IV 
TA systems is the classical toxin-antitoxin bicistronic operon with an upstream 
antitoxin gene [107]. cbeA/cbtA of E. coli is the best studied type IV TA system 
[107–109]. The CbtA toxin inhibits cell division by binding to cytoskeletal 
proteins MreB and FtsZ and preventing their polymerization [109]. Cells be-
come lemon shaped in bacterial cultures where CbtA is overexpressed. In vitro, 
CbtA inhibits the GTPase activity of FtsZ, yet MreB retains its ATPase activity 
[109]. A recent genetic study reports that CbtA binds to the H6/H7 loop of 
GTP-binding N-terminal domain of FtsZ and to the flat surface of MreB, which 
is required for the formation of double filaments [110]. CbeA antitoxin binds to 
MreB and FtsZ and enhances their filament bundling [108]. Toxins of two 
cbtA/cbeA homolog systems, YkfI and YpjF of E. coli, also inhibit growth and 
induce lemon-shaped cells when overexpressed. Prolonged expression of these 
toxins leads to cell lysis. Both toxins interact with FtsZ, but only YpjF has been 
shown to interact with MreB [110,111]. 
abiEi/abiEii of Lactococcus lactis and its homologs are also hypothesized to 
act as type IV TA systems [112]. The hypothetical toxin AbiEii is a GTP-
binding nucleotidyltransferase with unknown working mechanism and target. 
Overexpressing AbiEii toxin of L. lactis or Streptococcus agalactiae in E. coli 
results in an impaired ability to form colonies, whereas no growth inhibition is 
seen when they are co-expressed with cognate AbiEi protein. Similar to type II, 
the bicistronic TA operon is repressed by the AbiEi antitoxin. These modules 
are speculated to belong to type IV TA systems because no interaction between 
the toxin and antitoxin has thus far been detected.  
 
 
1.1.5. Type V toxin-antitoxin systems 
In Type V TA systems the antitoxin is RNase which degrades the toxin mRNA 
(Figure 1). Currently, only one representative of type V is known: the ghoST of 
E. coli. The genes are again located in a bicistronic operon. The GhoT toxin is a 
small transmembrane protein similar to the Hok family of type I toxins [113]. It 
forms multimers that act as transmembrane pores [114]. Overexpression of 
GhoT results in membrane damage that leads to cell lysis. An in vitro cleavage 
assay showed the GhoS antitoxin to be an endoribonuclease that preferentially 
cleaves the GhoT portion of ghoST mRNA. RT-qPCR revealed that in statio-
nary phase the ghoS mRNA is ~20 times more stable than that of ghoT [113]. 
This implies that in stationary phase the GhoT toxin is strictly controlled by the 
antitoxin. Overexpression of GhoS does not inhibit cell growth, meaning that its 
RNase activity is highly specific. Also, GhoS does not regulate the ghoST pro-
moter [113]. 
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1.1.6. Type VI toxin-antitoxin systems 
socAB of Caulobacter crescentus is so far the sole studied representative of type 
VI TA systems (Figure 1) [115]. socA and socB form a bicistronic operon where 
the antitoxin gene is located upstream. socB was discovered during a screen for 
genes that make ClpXP protease essential in the Caulobacter. Overexpressing 
SocB with a modified C-terminus, that makes it unable to interact with ClpX, 
leads to growth inhibition, cell filamentation, and the SOS response. SocB inhi-
bits the elongation of replication by binding to β sliding clamp (DnaN) and 
blocking its interactions with DNA Polymerase III. SocB toxins seem to have 
high target specificity because SocB of C. crescentus is not toxic within E. coli. 
SocA antagonizes the toxicity of SocB by promoting its degradation by the 
ClpXP protease. In vitro cleavage experiments indicate that SocA acts as an 
adapter that brings SocB close to the ClpX pore. According to bioinformatic 
analysis, socAB homologs are found only in α-proteobacteria. 
 
 
1.2. Distribution of toxin-antitoxin systems 
Many in silico methods have been developed to identify new TA systems 
(excellent overview by Lobato-Márquez et al.[18], two recent studies by Xie 
Yet al. [14], and Coray  et al. [116]). In general, TA systems are abundant in 
chromosomes and plasmids of bacteria and archaea [12–14,116,117]. Chromo-
somal TA systems often locate in mobile regions such as super-integrons and 
prophages [12,118,119]. The repertoire of TA systems differs between closely 
related strains indicating the high genetic mobility of these elements [16]. Some 
confined studies report higher TA counts in pathogenic bacterial strains com-
pared to their non-virulent relatives (reviewed by Lobato-Márquez et al. [18]). 
The prevalence of TA systems is biased towards type II, which make up the 
lion’s share of all TA loci. They are widely distributed, potentially due to their 
susceptibility for horizontal transfer. Type III TA systems also seem to be prone 
to horizontal transfer and are found in many different phyla [9,100,116]. Type I 
TA loci generally have a narrow phylogenetic distribution [116,120] and are 
rarely found on plasmids [116]. As expected, type I toxin families found on 
plasmids have a wider distribution [116]. However, the prevalence and diversity 
of type I TA systems may actually be higher than current studies show because 
searching for type I TA systems is difficult due to their short toxin and highly 
variable antitoxin sequences. The putative type IV abiEi/abiEii TA  systems 
seem to be ubiquitous in bacterial and archaeal genomes [112]. As already 
mentioned, homologs of the type VI TA system socAB have only been detected 
in α-proteobacteria. To the best of our knowledge, the distribution of type IV 
cbtA/cbeA and type V ghoST TA systems have not been studied. 
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1.3. Biological functions of toxin-antitoxin systems 
Because many TA systems are prevalent in the mobilome, are prone to hori-
zontal transfer, and stabilize plasmids and labile genomic regions, researchers 
have speculated that they primarily act as selfish genetic units. By this theory, 
TA systems are addictive modules that propagate themselves on the expense of 
the host as they help to maintain the genetic elements carrying their genes 
(Figure 3A) [16]. Such selfish elements should be easily inactivated by a single 
mutation in the toxin gene. Many toxins have indeed shown to be inactive in 
their host (several hok family members in E. coli K-12 [121]) or close relatives 
of the host (half of the repertoire of M. tuberculosis toxins did not inhibit the 
growth of Mycobacterium smegmatis [15]). On the other hand, there are abun-
dant chromosomal toxins capable of growth inhibition and several TA systems 
are associated with different phenotypes. For example, deletion of chromosomal 
TA systems have resulted in increased susceptibility to bacteriophages [9], 
decreased antibiotic tolerance [7], or lower virulence [18]. It is likely that many 
TA systems indeed only act as selfish entities, yet some seem to be integrated 
into cellular networks or are beneficial to the cell on their own merit (Figure 3). 
Still, the biological function of most TA systems remains elusive, possibly due 
to their redundancy, as several TA systems may carry the same function. Here, 
we discuss the suggested roles of TA systems in bacterial physiology. 
 
Figure 3. Speculated functions of toxin-antitoxin systems. (A) The selfish module 
model represented by plasmid addiction. This model sees TA systems as selfish entities 
which propagate themselves and mobile genetic elements carrying them. Toxins, being 
more stable than antitoxins, become active in daughter cells that have lost the TA 
systems. The growth of these cells gets shut down or they get killed, giving growth 
advantage to bacteria inheriting the TA systems. (B) Stress response model. Some TA 
systems are hypothesized to be integrated in cellular stress response networks. Antitoxin 
pool gets depleted during stress while the more stable toxins persist. Freed toxins help 
cells to cope with stressful conditions. Common hypotheses for helpful toxin activity 
include growth inhibition to accommodate with stressful conditions, altruistic cell death 
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during bacteriophage infection and regulation of specific genes. Antitoxin genes and 
proteins are depicted blue, toxin genes and proteins pink. TA systems are depicted as 
type II modules where toxins are inactivated by direct interactions with antitoxin. 
 
 
1.3.1. Stabilization of mobile genetic elements 
Several plasmid-borne TA systems have been shown to protect against plasmid 
loss. The antitoxins need to be constantly produced to counter toxins. When a 
plasmid is lost, the antitoxin pool depletes quickly and toxins become free to 
inhibit cell growth. Therefore, daughter cells without the plasmid have their 
growth shut down or are killed [16]. Propagation of the R1 plasmid by the type 
I hok/sok TA system [10] and the F-plasmid by the type II ccdAB TA system 
[11] are the best studied examples of plasmid stabilization. Type III and IV TA 
systems have also been shown to stabilize plasmids. The type III TA systems 
toxIN of Pectobacterium atrosepticum and cptINEr of Eubacterium rectale have 
been shown to stabilize a model plasmid in E. coli strain W3110 and ToxIN of 
Bacillus thuringiensis was observed to maintain a model plasmid in B. subtilis 
YB886 [103]. The hypothetical type IV TA system abiEi/abiEii of Strepto-
coccus agalactiae was shown to stabilize plasmids within E. coli DH5α [112].  
TA systems can also promote plasmid maintenance through more sophis-
ticated pathways. For example, a drop in copy number of R1 plasmid results in 
the activation of the Kid toxin of kis/kid TA system, likely due to the shortage 
of new antitoxins [122]. Kid is a ribosome-independent endoribonuclease toxin 
that recognizes the UUACU sequence. One of the targets of Kid is an antisense 
RNA that represses the production of R1 plasmid replication protein RepA, 
whereas RepA itself remains untouched by the toxin. Thus, Kid enhances 
plasmid replication by derepressing RepA production and halting cell growth 
until the number of R1 plasmids increases [122]. 
Cooper et al. [123] argue that having TA systems in plasmids is mainly bene-
ficial for plasmid-plasmid competition. They show that the parDE system helps to 
out-compete plasmids without the TA system. Thus, when plasmids are not 
compatible, TA systems can help to ensure the prevalence of its carrier [123].   
Several TA systems have been shown to stabilize labile regions of chromo-
somal DNA (reviewed by Van Melderen [17] and by Cambray et al. [118]). 
Still, not all TA systems can stabilize mobile genetic elements as some tested 
chromosomal TA systems fail to secure plasmid maintenance (reviewed by 
Harms et al. [7], and by Van Melderen and Saavedra De Bast  [16]). 
 
 
1.3.2. Anti-addiction 
Chromosomal TA systems can guard against mobile genetic elements that are 
stabilized by homologous TA systems. The antitoxins produced by chromo-
somal TA systems can, in some cases, neutralize homologous plasmid borne 
toxins and thus allow for plasmid loss. For example, ccdAB of Erwinia chry-
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santhemi was shown to cure E. coli MG1655 from F plasmid-derived ccdAB 
addiction [124]. Interestingly, ccdBA from E. coli O157:H7 does not protect 
against F plasmid addiction [125]. Mobilome stabilizing TA systems are pro-
bably under constant evolutionary pressure for their toxins to be uniquely 
antagonized by cognate antitoxins. 
 
 
1.3.3. Abortive infection 
Abortive infection is the altruistic suicide of bacteria during viral attack to stop 
the spread of the infection in the population [7]. Many TA systems activate during 
bacteriophage infection and halt the advancement of the phage. It is unknown 
how viral infections trigger TA systems, but it is likely that the changes in 
translation or transcription unbalance the toxin/antitoxin ratio and free the toxins. 
hok/sok of E. coli K-12 R1 plasmid strongly supresses, and mazEF of E. coli K-
12 partially supresses, T4 infection [126,127]. Members of the toxIN and tenpIN 
TA families abort infections by a variety of bacteriophages (reviewed by Goeders 
et al. [9]). The hypothesized type IV TA system abiEi/abiEii of Lactococcus 
lactis has been shown to provide protection against the φ712 phage [112,128]. 
The importance of TA systems in combating bacteriophages is supported by 
the existence of numerous phage borne mechanisms that neutralize the TA 
systems. The Dmd protein encoded by the T4 bacteriophage acts as antitoxin for 
the RnlA toxin of E. coli K-12 and LsoA toxin of E. coli O157:H7 plasmid 
pOSAK1 and counters their toxicity during infection (reviewed by Otsuka 
[129]). Upon the deletion of the dmd gene, the lsoAB and rnlBA TA systems 
effectively suppress T4 infection [48,130]. T4 also encodes for the Alt protein, 
which adds an ADP-ribosyl group to the MazF of E. coli. ADP-ribosylated 
MazF has lower endoribonuclease activity in vitro. However, deleting alt does 
not affect the virulence of T4, indicating that other inhibitors of MazF might be 
involved [126]. The Gp4.5 protein of bacteriophage T7 inhibits the activity of 
Lon protease in E. coli K-12 and thus protects protein antitoxins from degra-
dation [117]. A screen was performed to identify φTE phage mutants that can 
escape abortive infection by the toxIN TA system of Pectobacterium atrosep-
ticum. All escape mutants had modifications in the φTE gene that encodes for 
RNA with motifs similar to type III antitoxins repeats [128]. Most escape 
mutants had expanded antitoxin motifs that were capable of neutralizing the 
toxin. One escape mutant obtained the toxI antitoxin through recombination 
between antitoxin repeats and the bacterial antitoxin gene [131]. Thus, some TA 
systems seem to be part of the arms race between phages and bacteria. 
 
 
1.3.4. Metabolic downregulation 
The increase in transcription of many TA systems during various stresses and 
the occurrence of stress specific regulatory elements upstream of several TA 
operons, have led to the hypothesis that TA systems regulate growth in stressful 
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conditions [17,57]. For example, amino acid and glucose starvation induce 
transcription of the mazEF, relBE, mqsRA, yafNO, and higBA TA systems in E. 
coli [47,132–134] and several type I toxins and type II TA systems in E. coli are 
preceded by LexA binding sites [7]. The ability of TA systems to downregulate 
metabolism may help to preserve resources under harsh conditions. This hypo-
thesis remains controversial because several studies fail to see any disadvantages 
in growth for TA system deletion strains during various stresses (reviewed by 
Van Melderen [17]). For example, deleting five TA systems from E. coli K-12 
did not affect the growth of the mutant during amino acid starvation, nutritional 
downshift, rifampin treatment, stationary phase, and acidic stress [135]. Neither 
did the absence of five TA systems affect recovery from these stresses [135]. 
 
 
1.3.5. Programmed cell death 
MazF of E. coli was reported by the Engelberg-Kulka’s group to be a part of 
altruistic cell death pathway triggered by extra cellular death factor EDF 
(reviewed by Kumar and Engelberg-Kulka [136], and by Engelberg-Kulka et al. 
[137]). Various stressful conditions (amino acid starvation, oxidative stress, 
treatment with transcription and translation inhibiting antibiotics and induction 
of DNA damage) are suggested to cause MazF-mediated cell death in majority 
of the population to provide nutrients for the few surviving cells. However, 
these data are highly controversial because other groups have not seen MazF-
mediated cell death neither under physiological conditions nor while over-
expressing the toxin [134,135,138,139]. These discrepancies may arise from the 
strains used: the authors of the MazF-mediated programmed cell death hypo-
thesis conducted their experiments with an E. coli strain deficient in relA, and 
their mazEF deletion strain was also deficient in mazG [135]. At the same time, 
other authors used strains where these genes remained intact. However, Tsili-
baris et al. also failed to see MazF-mediated cell death when exposing the same 
relA deficient strain used by Engelberg-Kulka’s group to conditions that were 
reported to activate the programmed cell death [135]. 
In Myxococcus xanthus, MazF was found to cause altruistic cell death during 
fruiting body formation [140]. However, the exact role of MazF in the process 
remains unclear because the effect of MazF is dependent on a mutation in the 
membrane secretin pilQ gene [141,142]. We conclude that there is currently no 
solid evidence to consider mazF as a gene involved in programmed cell death. 
 
 
1.3.6. Persisters 
The metabolic downshift caused by TA systems is thought to play a role in 
generating persister cells [7]. Persisters are a dormant subpopulation of bacteria 
that are tolerant to multiple antibiotics (reviewed by Page and Peti [19], and 
Lewis [143]). After the antibiotic treatment ends, persisters resuscitate and 
restore the population. The exact mechanisms which make persisters insensitive 
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to antibiotics are as of yet not clear, however, their low metabolism is thought 
to be an important factor because most antibiotics only corrupt active processes. 
Persisters make up a tiny fraction of the population in exponentially growing 
culture (~10-6 in E. coli), however, their numbers increase drastically in statio-
nary phase (up to ~10-2 in E. coli). Occurrence of persisters under favourable 
growth conditions has been hypothesized to be a bet hedging strategy at the 
population level: a few bacteria are prepared for potential abrupt changes in the 
environment at the cost of lower fitness in the current environment. The 
tolerance to antibiotics correlates with cell growth rate [144,145], so it is ex-
pected that the number of persisters increases under growth limiting conditions. 
A mutant of E. coli’s HipA toxin, hipA7, was the first persistence increasing 
genotype discovered [146]. Activation of HipA leads to the stringent response 
which may induce persister generation [147]. On the other hand, deletion of 
hipBA in E. coli does not affect persistence [132,148]. TA systems and per-
sisters were further linked by reports that the E. coli and M. tuberculosis cells 
that survive antibiotic treatment have high transcript levels of several TA genes 
[132,149,150]. Also, the overexpression of toxins increases persistence, how-
ever, so does the overproduction of other cellular proteins with growth inhi-
biting capabilities [132,151,152].  
Recently, the results of research by Kenn Gerdes’s group that associated 
persister formation with TA systems were retracted. The authors initially saw 
that step by step deletion of ten TA systems of E. coli gradually decreases the 
number of ampicillin and ciprofloxacin tolerant cells [153]. Further study 
revealed that the phenotype was caused by contamination by the ϕ80 bacterio-
phage [154]. Gerdes’s group also claimed that induction of relBE and yefM/ 
yoeB TA systems in E. coli correlates with antibiotic tolerant cells [155]. They 
based their theory on a microfluidics experiments with green fluorescent protein 
(GFP) tagged TA system genes. These results have been challenged by Goor-
maghtigh et al. [156] who demonstrated that GFP is not a suitable reporter for 
these experiments due to its weak signal that stays below the level of bacterial 
autofluorescence. No correlation between the induction of relBE and yefM/yoeB  
TA systems and persister cells was detected when using mScarlet-I based 
reporters [156]. 
There are some TA systems that have been directly linked with peristers. For 
example, TisB toxin of E. coli provides strong supporting evidence for being 
involved in the formation of persisters [152]. Deletion of tisB reduces the amount 
of ciprofloxacin tolerant cells by 10- to 100-fold [152]. DNA damage caused by 
ciprofloxacin triggers the production of TisB as the expression of toxins depends 
on the SOS response [152]. Also, type II TA pasTI plays a part in E. coli CFT073 
strain persister generation, but not in MG1655. ΔpasTI CFT073 has a 100-fold 
reduced ampicillin and ciprofloxacin tolerant cell count in vitro and reduced 
ability to infect mice kidneys [157]. Another in vivo experiment, this time with 
Salmonella Typhimurium, shows persistence being reduced in bacteria colonizing 
mice macrophages in several single TA deletion mutants [158]. In summary, 
persister formation appears to not be the major function for most chromosomal 
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TA systems, as initially speculated. Nevertheless, some TA systems seem to 
contribute to the generation of antibiotic tolerant cells. 
 
 
1.3.7. Transcriptional regulation 
When discussing the activities of TA systems, the effects of toxins are usually 
addressed, however, in some cases the antitoxins also affect the phenotype of 
bacteria. Some type II antitoxins interact with promoters beyond their own 
operon. The MqsA antitoxin of E. coli K-12 mqsRA TA system represses the 
expression of several genes, most prominently the sigma factor rpoS and curli 
regulator csgD [159,160]. MqsA is thought to regulate biofilm formation by 
controlling these two genes. Degradation of MqsA by Lon under stressful 
conditions such as oxidative stress, frees rpoS and csgD from inhibition and 
promotes biofilm formation [159]. The DinJ antitoxin of E. coli K-12 dinJ/yafQ 
TA system represses the csgE gene, which is a positive modulator of RpoS 
translation [161]. However, deleting the dinJ/yafQ system does not affect 
growth during various stresses [135]. HipB antitoxin of E. coli K-12 hipBA was 
shown to bind to promoters of relA, eutH and fadH genes, and negatively 
regulate their expression [162]. Bioinformatics analysis predicts that 33 genes 
are being regulated by HipB [162]. S. aureus’s savRS TA system was reported 
to repress virulence genes hla and efb [163]. These examples show that bacteria 
are able to utilize type II antitoxins in their regulatory circuits. Antitoxins may 
act as stress sensing units that allow for quick derepression of stress response 
genes due to their labile nature. However, more data are needed to verify 
whether these interactions also result in beneficial phenotypes. 
 
 
1.3.8. Translational regulation of specific genes 
Endoribonuclease toxins with long recognition sequences have been hypo-
thesized to regulate the translation of specific set of genes because five to seven 
nucleotide cleavage recognition sequences are likely absent or inaccessible in 
most genes [5]. Yet, to the best of our knowledge, there are no proven examples 
of this hypothesis. Still, there are interesting cases waiting for further study. The 
previously described MazF toxin of Haloquadratum walsbyi that recognizes a 
seven nucleotide cleavage site is inactive in the high salinity growth environ-
ment, but cleaves RNA effectively at lower salinity [72]. H. walsbyi floats on 
saturated salt water and uses light to produce a proton gradient via bacteriorho-
dopsin for ATP production. In case of fresh water influx, H. walsbyi is spe-
culated to lose its ability to float on salt water and ATP production decreases. 
As MazF is active at lower salt levels, the decrease in salinity could activate 
MazF. The transcriptional activator of rhodopsin has three MazF recognition 
sequences, thus making regulation of rhodopsin expression a potential role for 
MazF of H. walsbyi [72]. 
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1.3.9. Reprogramming of the translational system 
A series of recent publications claim that the MazF toxin completely repro-
grams the translation of E. coli MC4100 (a K-12 derivate) [1,2,71]. MazF was 
shown to cleave 43 nucleotides from the 3’ end of 16S rRNA under various 
stressful conditions [1]. During amino acid starvation induced by serine hydro-
xamate, 80% of the 16S were estimated to be cut in wild type, but not in a 
ΔmazEF mutant strain. Ribosomes with truncated 16S were termed as stress 
ribosomes and were reported to specifically translate leaderless mRNAs in vitro 
[1]. A later study stated that cleavage anywhere in the 5’ untranslated region 
(UTR) is sufficient for stress ribosomes to form initiation complexes in vitro 
[2]. RNA sequencing of a MazF overexpression culture identified 330 genes 
whose mRNAs were cut in 5’ UTR by the toxin in polysome fraction and were 
termed to constitute MazF regulon. Consequently, MazF was hypothesized to 
become active during stress and inactivate most mRNAs through ORF cleavage, 
but at the same time ensure the translation of stress genes [2]. 
RtcB was reported to religate the 43 nucleotide fragment back to 16S and 
restore the original mature ribosomes [71]. The cleaved 43 nucleotide fragment 
was reported to be stable and co-migrate with 30S subunit fraction, and thus 
implying a direct interaction. In vivo re-ligation was allegedly shown during 
recovery from serine hydroxamate induced amino acid starvation. Such a 
system would elegantly preserve resources otherwise wasted on truncated 30S 
degradation and re-synthesis, and allow for faster recovery from stress.  
A recent study by Culviner & Laub failed to find any evidence for such an 
elaborate stress response mechanism for MazF of E. coli K-12 [69]. RNA 
sequencing conducted with a short term MazF overexpression culture showed 
extensive cleavage in coding regions across all the transcriptome, but identified 
only 41 genes with truncated 5’ UTR. Most of the 5’ UTR cleaved genes also 
had strong cleavage sites within ORF. Cleavage in the coding region was 
verified by northern blot for several model transcripts of MazF regulon. This 
implies that the 5’ UTR cleaved genes can’t be translated into complete 
products. MazF expression also reduced the ribosome density at the 3’ end of 
transcripts, indicating that MazF generated cleavage halts translation. Ribosome 
profiling did not show increased translation for 5’ truncated transcripts. MazF-
dependant generation of stress ribosomes was also challenged. An hour long 
overproduction of MazF generated an insignificant amount of 43 nucleotide 16S 
3’ end fragment. Also, pulse labelling experiments showed that MazF attacks 
freshly synthesized rRNA precursors, and not the rRNA in mature pre-existing 
ribosomes. Thus, it is unlikely that MazF reprograms the translational machi-
nery of E. coli. 
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1.3.10. Bacterial virulence 
TA systems seem to promote virulence in several pathogenic bacteria, summa-
rised in a recent review by Lobato-M´arquez et al. [18]. Intriguingly, there are 
several pathogens whose virulence is reduced upon TA deletion(s) [157,164–
168]. As pathogens encounter several dangers while colonizing the host, all 
previously presented hypothetical stress coping mechanisms would probably 
benefit virulence. The stabilization of virulence plasmids or pathogenicity 
islands plays an important role in virulence, exemplified by pAD1 plasmid 
stabilization by RNAI/RNAII in Enterococcus faecalis [33,169] and SXT 
element stabilization by mosAT in Vibrio cholerae [170]. Control of biofilm 
formation, as demonstrated by the mqsRA system of E. coli K-12 [159,160], is 
of vital importance for pathogenicity of many bacteria [18]. Deletion of relBE-
1, relBE-4, and relBE-7 TA in Vibrio cholerae seem to influence biofilm forma-
tion via an unknown mechanism [167]. Although it is puzzling why deleting 
relBE-2, which is identical to relBE-7, has no phenotype [167]. 
TA system deletions in uropathogenic E. coli, non-typeable Haemophilus 
influenza, Salmonella Typhimurium, Vibrio cholera, and Mycobacterium tuber-
culosis were shown to decrease survival in ex vivo and/or in vivo infection 
models [18]. In Neisseria gonorrhoeae, the transposon insertion in fitAB TA 
system increases the intracellular proliferation of the bacteria in a model cell 
culture, implying that fitAB plays a role in growth regulation [171].  An increase 
in virulence and proliferation was seen after deletion of the sRNA antitoxin 
ef0408-0409 regulating type I toxin ef0409 of Enterococcus faecalis [172]. The 
hyper-virulence may be due to uncontrolled toxin activation or the sRNA might 
regulate some virulence-associated gene(s).  
Two pathogens are speculated to have weaponized TA systems by secreting 
the toxin to lyse host cells [18]. Staphylococcus aureuses sprG1 locus encodes 
for two type I toxins, whose expression is post-transcriptionally controlled by 
SprF1 antitoxin RNA [173]. Both of these toxins have been found in the 
extracellular space and shown to lyse erythrocytes and bacteria  [173]. Still, no 
in vivo lysis or virulence data following the deletion of sprG1 has been 
presented. The toxins of chpIK and mazEF TA systems of Leptospira inter-
rogans were reported to be found in macrophages during ex vivo infection 
[174]. One major concern is that this experiment lacked negative controls where 
the TA systems were deleted. 
These results are only the first steps in our understating of the roles TA 
systems play in virulence. One has to be extra careful when interpreting trans-
poson mutagenesis and single TA system component deletion experiments 
because these may easily give raise to artefacts of gene regulation. There are 
almost no data that explain the mechanisms whereby TA systems promote 
virulence and much work is required to understand how they function. 
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1.4. Recovery from toxin activity 
Considering that TA systems potentially regulate growth and virulence, reco-
very from toxin activity is an important step of TA regulation. The first step in 
recovery is neutralizing the toxins. As described previously, many type II 
antitoxins have higher translation rates than their cognate toxins or a portion of 
the toxin mRNAs are truncated. This ensures that after the stress ends, the 
antitoxins are synthesized in excess of the toxins and quickly neutralize the free 
toxins. As type II antitoxins also repress the TA promoter, their shortage results 
in a high number of TA transcripts. Recovery from toxin activity is faster due to 
many antitoxin templates provided by the uninhibited TA operon. Rapidly 
increasing the amount of antitoxin inhibits the toxins and represses the TA 
promoter [7,56]. Notably, the majority of toxins with a hypothesized role in 
stress tolerance or virulence belong to type II. Several type I toxins are 
controlled by external regulators, for example LexA regulates the transcription 
of TisB [152], and thus toxin production can be shut down by varying their 
regulator concentrations. 
Several antitoxins also promote recovery by reversing the corruption done 
by toxins. CcdA dislodges CcdB from gyrase, thus restoring its activity [175]. 
DarG antitoxin removes the ADP-ribose groups, added by the toxin DarT, from 
the single stranded DNA [99]. Normal cellular regulatory mechanisms also 
promote the recovery: tmRNA rescues halted ribosomes from mRNAs cleaved 
by ribonuclease toxins and peptidyl-tRNA hydrolase recycles aminoacyl-tRNAs 
acetylated by TacT toxin (reviewed by Hall et al. [56]). 
Some toxins regulate their own toxicity, which can be interpreted as in-
surance to avoid lethal damage. For example, MazF of E. coli K-12 cleaves its 
own mRNA [176]. HipA toxin, which acts as kinase, inactivates itself by 
autophosphorylation at position Ser150 [177]. The majority of HipA and its main 
target, glutamyl-tRNA synthetase, molecules are phosphorylated in HipA over-
expression experiments [178]. Effective autophosphorylation should ensure safe 
levels of active HipA and allow for quicker recovery from damage caused by 
the toxin.  Also, as mentioned before, the membrane damage caused by HokB 
of E. coli K-12 is hypothesized to reduce the activity of RNase E, a degrader of 
SokB antitoxin [31]. Thus, toxins can regulate their own toxicity by inactivating 
themselves or by stabilizing their antitoxins. 
In principle, all the mechanisms which are hypothesized to help the recovery 
from toxin damage can be seen as protection from accidental activation. For 
example, if the toxin amount of a plasmid stabilizing TA system increases 
stochastically, it would not instantly cause major harm to the cell. 
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1.5. Network of toxin-antitoxin systems 
Considering the abundance of TA systems in bacteria, some overlap in function 
is expected and TA systems may be integrated into networks. For example, 
many type II TA systems are thought to be switched on through the degradation 
of antitoxins by the same proteases [5]. TA systems preceded by LexA boxes in 
E. coli K-12 could all see increased transcription in case of DNA damage [7]. It 
has been hypothesized that TA systems able to induce abortive infection could 
respond to the same viral signals and activate in bulk [9]. In some cases, a toxin 
directly regulates the production of other toxins. For instance, overexpression of 
MqsR in E. coli results in the cleavage of ghoS antitoxin mRNA, and the 
production of GhoT toxin [179]. On the other hand, keeping redundant genes in 
bacteria wastes resources and when TA systems indeed activate under exactly 
the same conditions without synergy, some of them are expected to become 
non-functional or lost from the genome. 
Many bacteria contain homologous TA systems, which raises the question 
whether the components of different TA systems interact. Studies that have tried 
to clarify this issue have mostly focused on type II TA systems. They have 
found that generally non-cognate proteins do not interact (reviewed by Goeders 
and Van Melderen [6]). Even components of highly homologous systems are 
rarely seen to form complexes. Cross-interactions may disturb the TA balance 
and cause unwanted toxin production, and thus be under negative selection. 
Nonetheless, there are several examples of TA cross-interactions in the same 
bacterium. Components of different relBE systems of M. tuberculosis were 
shown to form complexes in E. coli and bind to promoters in vitro [180]. Inter-
actions were also seen between various components of mazE-vapC and mazEF 
systems of M. tuberculosis in pull-down experiments conducted in E. coli [181]. 
The function of these interactions remains unclear. 
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2. AIMS OF THE STUDY 
Endoribonuclease toxins of E. coli have been classically viewed as growth in-
hibitors that act by cleaving the bulk of the mRNA [3]. Recently, the MazF 
toxin of E. coli was proposed to be a centrepiece of an elaborate stress response 
system, capable of reprogramming translation [1,2]. According to this theory, 
MazF alters the translational preference of ribosomes by removing the anti-
Shine-Dalgarno sequence from 16S rRNA. These truncated ribosomes are 
reported to specifically translate 5’ UTR-truncated transcripts of stress-related 
genes, which are also generated by MazF. We saw in our preliminary experi-
ments that overexpression of MazF or MqsR toxin results in large fragments of 
rRNA. This result contradicts with the hypothesis of MazF-mediated translatio-
nal reprogramming. The fragmentation of rRNA by MazF and MqsR implies 
that these toxins may either cleave rRNA at different sites in mature and 
functional ribosomes or, alternatively, cleave only the unstructured precursor 
rRNA. Thus, we aimed to study the rRNA cleavage following the overexpres-
sion of MazF and MqsR to examine which of these hypotheses holds true and to 
test whether MazF generated stress ribosomes really do exist. We also studied 
mRNA cleavage by MazF to clarify whether MazF generates a specific pool of 
stress-related transcripts with truncated 5’ UTR-s or it attacks mRNAs without 
bias. 
It has been speculated that several TA systems contribute to growth inhibi-
tion under the same stressful conditions and in antibiotic tolerant cells [47,132–
134]. We tested the possibility of a TA network where transcription of one or 
more TA systems is induced by the production of non-cognate toxins. Finally, if 
chromosomal TA systems are indeed involved in growth regulation, cells 
should be able to recover from their expression. Thus, we were interested in 
whether bacteria can resume growth after being exposed to toxin overexpres-
sion. 
In summary, the specific goals of this research were: 
1)  to study the rRNA cleavage by MazF and MqsR in E. coli (publication II) 
2)  to map and analyse mRNA cleavage patterns generated by MazF and MqsR 
in E. coli (publication III) 
3)  to study how E. coli can recover from the overexpression of toxins (publi-
cation I, III) 
4)  to study if toxins can activate transcription of non-cognate type II TA 
operons (publication I, III) 
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3. RESULTS AND DISCUSSION 
3.1. Transcription of toxin-antitoxin systems can be 
activated by expressing non-cognate toxins 
Bacteria usually have many TA systems, several of which are transcriptionally 
triggered under the same conditions. For example, in E. coli the relBE, dinJ/ 
yafQ and mazEF have higher expression levels in dormant cells that survive 
lysis by ampicillin and mazEF, relBE, mqsRA, yafNO, and higBA have in-
creased transcript levels during glucose and amino acid starvation [47,132–
134]. The operons of most type II TA systems are repressed by their TA 
complexes and/or antitoxins [6,19,42]. Thus, the transcriptional activation of 
TA operons could indicate a drop in antitoxins and the liberation of toxins. To 
study the possibility of an interconnected network of TA systems, we tested 
whether the transcription of type II TA operons can also be activated by non-
cognate type II toxins. Northern blot analysis revealed that overexpressing 
MazF, MqsR, HicA, or HipA toxins in E. coli BW25113 leads to transcriptional 
activation of the relBEF operon within an hour (publication I; Figure 1). Also, 
ectopic RelE production results in activation of the mazEF, mqsRA, hicAB, 
dinJ-yafQ, yefM-yoeB, and prlF-yhaV TA systems (publication I; Figure 2). 
Transcriptional cross-activation is not a universal phenomenon between all TA 
systems because only the production of YafQ, RelE, and HipA, but not MazF 
and HicA, increase the mqsRA transcript level in E. coli (data not shown). We 
also studied the transcriptional activation of TA systems during mupirocin-
induced amino acid starvation. We used northern blot analysis to measure the 
relative RNA levels of mazEF and mqsRA in E. coli BW25113 and 
BW25113ΔrelBEF strains. The transcription of both systems increased in the 
wild type strain, but only mqsRA was activated in the relBEF knock-out (publi-
cation I; Figure 3). This shows that transcriptional cross-activation also happens 
under physiologically relevant conditions.  
Degradation of antitoxins by proteases is commonly considered to be the 
main reason for TA system activation [6,7,19,42]. We tested whether the 
transcriptional activation of the relBEF operon by non-cognate toxin expression 
is affected in a protease deficient E. coli strain. To our surprise, cross-activation 
also happened in a triple protease knockout strain that lacked the genes that 
express the proteases Lon, ClpPX, and HslVU (publication I; Figure 4). 
Although Lon and ClpPX are commonly associated with antitoxin degradation 
[49], it seems that other proteases of E. coli also effectively eliminate antitoxins. 
Because new antitoxins are not synthesised during the translational arrest 
induced by the overexpressed toxins, and existing ones are rapidly degraded, 
TA operons become derepressed. This model contradicts with our experiments, 
which show that only some toxins activate the transcription of mqsRA (data not 
shown) and that relBEF is required for transcriptional upregulation of mazEF 
during amino acid starvation (publication I; Figure 3). It is possible that, under 
35 
some of our conditions, the activation of TA systems was also controlled at the 
post-transcriptional level: all of the toxins we tested, except for HipA, were 
ribonucleases that effectively cleave mRNAs of many non-cognate TA systems 
(publication I; Figure 1, Figure 2). Because the cleavage specificity of endoribo-
nucleases differs, some TA transcripts may be left untouched by the non-
cognate toxin and enough antitoxin gets produced to repress the TA operon. All 
experiments described until now were performed by Villu Kasari. 
We also looked for transcriptional cross-activation of TA systems in random 
primed paired-end RNA sequencing data that was obtained from bacteria 
challenged with overexpression of MazF or MqsR for two hours. We again saw 
that type II toxins can activate non-cognate type II TA systems (publication III; 
Figure 1A, B, E, Data Set S2). The relative transcript levels of the type II anti-
toxins higA, relB, and rnlB, and the type II toxins relE and hipA displayed at 
least a five-fold increase in response to both MazF and MqsR overexpression 
(publication III; Data Set S2). MqsR production led to additional increase in the 
levels of the type II antitoxin genes prlF and hipB, and the type II toxin genes 
yoeB, higB, and chpB. Again, several type II TA systems remained uninduced, 
which indicates some specificity of cross-activation. We also observed an 
increase in the transcript levels of many type I TA system genes following 
MazF or MqsR production. Transcription of the type IV antitoxin yafW was 
induced by both toxins and the type IV toxin ykfI by MazF (publication III; 
Data Set S2). The transcriptional increase of type I and type IV TA genes in 
response to MazF and MqsR cannot be caused by the proteolysis of antitoxins 
because type I antitoxins are RNAs and the antitoxins of type IV TA systems 
with upregulated mRNA levels have not been shown to repress their TA 
operons. Interestingly, all the upregulated type I and type IV TA systems loca-
lize in prophages. Thus, their expression may be the result of prophage activa-
tion during translational inhibition that was induced by endoribonuclease toxins. 
 
 
3.2. E. coli cells recover from  
90 minute transient toxin expression 
Overproduction of toxins is a standard method of studying their effects on 
cellular growth. The downside of this approach is that very high toxin levels 
may be lethal to the cell and may not represent normal physiology following 
toxin expression. Therefore, we were interested if E. coli can recover from over-
production of the toxins that we used in most of these experiments. We 
monitored the recovery of single cells from transient toxin production using 
GFP dilution. GFP was synthesized in growing cells for 2.5h; then the medium 
was changed to stop the production of GFP and induce the synthesis of toxins. 
Toxins were then produced for 90 min before transferring cells to a growth 
medium without the inductor. Flow cytometry was used to measure the dilution 
of GFP: the more the cells divide, the weaker their GFP signal is. All of the 
bacteria recovered from 90 min overexpression of MazF, MqsR, RelE, and 
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HipA toxin (publication I; Figure S6). The regrowth following RelE and HipA 
expression was rather uniform. MazF and MqsR production generated hetero-
geneity: a subpopulation of cells began growing later. Our results show that a 
few hours of RelE, HipA, MazF and MqsR expression is not lethal to E. coli, 
although they may strongly inhibit the growth of part of the population. 
 
 
3.3. MazF and MqsR of E. coli cleave precursor rRNA at 
several positions 
Both ribosome-dependent and -independent ribonuclease toxins of E. coli are 
considered to act by degrading mRNA [3]. As an exception, rRNA was recently 
shown to be targeted by the MazF toxin [1]. MazF reportedly generates specia-
lised stress ribosomes by removing a 43 nucleotide fragment from the 3’ end of 
the 16S rRNA [1]. The ribosomal fraction with 3’ trimmed 16S rRNA was 
extracted from MazF expression culture and shown to specifically translate 
leaderless mRNAs in vitro [1]. This ribosomal fraction has also been reported to 
form initiation complexes with mRNAs that have truncated 5’ UTR [2]. All 
mRNAs that were translated in vitro corresponded to MazF cleavage products. 
The 43 nucleotide fragment of 16S rRNA was reported to stay connected with 
the stress ribosome and be religated to restore normal ribosomes after stress 
ends [71]. 
We observed much larger rRNA cleavage products while doing quality 
checks for RNA extracted from the MazF overexpression experiments in E. 
coli. These fragments could result from the activity of MazF and/or other 
endoribonucleases triggered due to MazF. Because rRNA degradation might be 
an overlooked mechanism by which toxins regulate growth in E. coli, we 
decided to further study the rRNA fragmentation by toxins. We analysed the 
integrity of rRNA following the overexpression of three ribosome independent 
ribonuclease toxins using northern blot analysis. Production of MazF and MqsR 
resulted in the fragmentation of 16S and 23S rRNA (publication II; Figure 1B, 
C), however, HicA left the rRNA intact (data not shown). Both MazF and 
MqsR expression generated distinct rRNA fragmentation patterns that indicate 
unique cleavage sites or activation of different ribonucleases. While over-
expressing MazF, we also saw the appearance of a 16S rRNAs 3’-end fragment 
corresponding to 43 nucleotides, but its intensity on northern blot was low 
compared to most other cleavage products (publication II; Figure 1C). 
To further study the rRNA fragmentation in response to expression of MazF 
and MqsR, we mapped the cleavage sites in two hour MazF and MqsR induc-
tion cultures using a modified version of differential sequencing developed by 
the Woychik group [73,182]. A long, two hour, expression time was used to 
maximize cleavage fragment accumulation. The cleavage site mapping method 
takes advantage of the differently modified RNA ends: the unprocessed 
transcripts have 5’-PPP and 3’-OH ends whereas most cellular processive 
RNases produce 5’-P and 3’-OH ends [183], and MazF generates 5’-OH and 
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2’3’-cyclic-P ends [68]. The RNA ends generated by MqsR were unknown 
prior to this study, but we assumed them to be the same as for MazF. E. coli 
lacks 5’-to-3’ exoribonucleases, thus making the 5’ portion of the fragments 
much more reliable for identifying cleavage sites. An adapter required for PCR 
amplification and sequencing was ligated to the 5’-P ends of the fragments. 
Thus, the 5’-P fragment ends correspond to the 5’ ends of mapped reads. To 
detect toxin cleavage sites, the 5’-OH ends were converted to 5’-P ends using 
the T4 polynucleotide kinase (PNK). Comparing untreated libraries with PNK 
treated libraries allowed us to reliably identify the cleavage sites. We compiled 
the reads of each library to a single composite rRNA because most of the reads 
mapped perfectly to all of the seven rRNA genes. We counted the number of 5’ 
read ends mapping to each composite rRNA position. Positions that displayed at 
least a 30-fold difference in 5’ end counts between untreated and PNK treated 
libraries that were located at a corresponding toxin recognition sequence (ˇACA 
for MazF and GˇCN for MqsR) were considered as primary toxin cleavage sites. 
We set a high threshold for the read count differences to ensure identification of 
strong cleavage sites. Also, the background noise in PNK treated samples was 
higher compared with the untreated samples, which was likely due to the non-
specific activity of endoribonuclease RNase I [183], which also leaves 5’-OH 
ends after cleavage. Thus, we needed a higher threshold that was clearly above 
the background noise that resulted from the random cleavage events by RNase 
I. Our assumption that MqsR generates the same RNA ends as MazF turned out 
to be true, because PNK treatment of MqsR expression cultures resulted in 
strong read stacks that specifically mapped to the GˇCN recognition sequence. 
We also mapped the 3’-ends of cleaved fragments to find out whether the 
truncated transcripts originate from mature ribosomes or precursor rRNA. 
Although the 3’ ends of cleavage fragments are very unstable, they provide a 
great way to differentiate between cleavage in mature ribosomes and precursors.  
Because ribosomes are highly structured and rRNA is covered with proteins, the 
exoribonucleases cannot process 3’ ends very far away from cleavage sites. The 
close proximity of 5’ and upstream 3’ cleaved ends would imply cleavage 
within ribosomes. The 3’ ends of fragments were mapped using poly(A) tailing.  
A poly(T)-adapter hybrid was used for cDNA first strand synthesis to ensure 
that the following amplifications and sequencing products would always contain 
reads with poly(A) tails. 3’ ends of fragments were traced to the beginning of 
the poly(A) tails. Because poly(A) tail synthesis requires 3’-OH groups, we 
generated a second library to also allow for identification of unprocessed toxin 
cleavage sites. The 2’-3’-cyclic-P ends were converted to 3’-OH ends using T4 
PNK and toxin cleavage sites were identified by comparing 3’ end counts per 
position in treated and untreated libraries. These cDNA libraries were prepared 
and sequenced by vertis Biotechnologie AG.  
These methods may encounter technical limitations in methylated regions of 
RNA, like some sites in mature rRNA, because methyl groups likely block the 
cDNA synthesis by reverse transcriptase. This needs to be taken into account 
when searching for the truncated 3’ ends of 16S rRNA in the hypothetical stress 
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ribosomes: the upstream region of the ˇ1500ACA site, which is speculated to be 
cleaved by MazF to generate specialized ribosomes, is heavily methylated in 
mature ribosomes. In addition, toxin cleavage products have different stability 
and one has to be extra careful while evaluating the degree of cleavage on the 
basis of toxin generated 5’ and 3’ ends. Read counts do not necessarily reflect a 
toxins’ preference for a cleavage site, but instead may show the stability of the 
cleavage products. 
RNA sequencing of 5’ ends revealed several primary MazF and MqsR 
cleavage sites in both 16S and 23S rRNA (publication II; Figure 2, Figure S5). 
These sites are at least partially double stranded in mature ribosomes or/and 
located deep inside the subunits (publication II; Figure 3). Thus, the sites are 
inaccessible to toxins in mature ribosomes and these cleavages most probably 
occurred on the unstructured rRNA precursors. We detected MazF cleavage 
also at the ˇ1500ACA site in 16S rRNA (publication II; Figure 2), which is the 
position reported to be cleaved in mature subunits to generate stress ribosomes 
[1]. In our experiment, the cleavage cannot originate from mature ribosomes. 
We used 100 nucleotide reads, which are too long to detect the 43 nucleotide 3’ 
end fragment of 16S rRNA. MazF also cleaved a 5’-precursor of 16S rRNA at 
position ˇ−46ACA. Because we performed sequencing in only one replicate, we 
verified several cleavage sites in total RNA using primer extension (publication 
II; Figure S12, Figure S13). Note that following the overexpression of MazF or 
MqsR, we also detected several sites with high 5’ end read counts that were 
independent of PNK treatment and did not map to toxin cleavage sequences 
(publication II; Figure S10). These sites are likely cleaved by ribonucleases 
involved in the cleanup of rRNA precursors that were damaged by toxins and 
cannot be packed into mature ribosomes. In addition, cleavage by toxins may 
induce rRNA refolding and open up attackable sites for other ribonucleases. 
Our 3’ sequencing data support our initial suspicion that MazF and MqsR 
mainly target precursor rRNA. In most cleavage sites identified by 5’ sequen-
cing, we did not detect 3’ ends in a nearby upstream region, which indicates 
extensive trimming that is not possible in highly structured mature ribosomes. 
As an exception, 3’ ends matching prominent MazF cleavage sites in the 
decoding center at positions ˇ1394ACA and ˇ1396ACA appeared only after PNK 
treatment (publication II; Figure S10). The decoding center of mature ribosomes 
should be inaccessible to toxins, so the reason why both 3’ and 5’ fragments are 
stable in these cleavage sites currently remains unclear. We failed to detect the 
3’ end of 16S rRNA at position ˇ1500ACA that would correspond to the truncated 
stress ribosome using RNA sequencing. We also checked for 16S rRNAs 3’ 
ends generated by MazF in total RNA using modified 3’-RACE (Rapid Ampli-
fication of cDNA Ends). Total RNA was treated with PNK and subjected to 
poly(A) tailing. First strand cDNA was synthesized using poly(T) primer, 
followed by PCR amplification, fragment separation by gel electrophoresis, and 
sequencing. Amplification products of total RNA samples not treated with PNK 
were used as a control. Again, we identified MazF generated 2’3’-cyclic ends at 
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the decoding center (publication II; Figure 5A, Figure S14B), but not at the 
ˇ1500ACA cleavage site. 
We also applied 3’ RACE to total RNA extracted under various conditions 
where the stress ribosome was reported to be formed. We hoped to see 3’ ends 
generated by MazF cleavage at ˇ1500ACA in stationary phase, chloramphenicol-
treated, and mupirocin induced amino acid starvation cultures. However, 3’ 
RACE failed to detect MazF generated 3’ ends under any of these conditions 
(data not shown). We used northern blot analysis to search for the 43 nucleotide 
fragment cleaved from the 3’-end of 16S rRNA under the same stressful 
conditions, but failed to detect it. The fragment did not appear even when using 
an exoribonuclease deficient strain where cleavage fragments accumulate (pub-
lication II; Figure S16B). Note, that our experiments do not completely rule out 
the possibility of stress ribosomes because our 3’ end identification methods are 
biased towards detecting precursors. Nevertheless, our results do not support the 
hypothesis of MazF-generated stress ribosomes. 
 
 
3.4. MazF- and MqsR-generated rRNA fragments are  
mainly found in aberrant subunits 
RNA sequencing and northern blot data show that overexpressing MazF or 
MqsR for two hours results in accumulation of precursor rRNA ends (publica-
tion II; Figure 4A, Figure S11B). A simple explanation would be that there are 
just not enough ribosomal proteins to correctly pack and process rRNAs due to 
the action of toxins that strongly inhibit translation. Formation of aberrant ribo-
somal subunits has been seen in response to several protein synthesis inhibiting 
antibiotics [184,185]. We analyzed ribosomal RNA fractions from sucrose 
gradients of two hour toxin expression cultures (prepared by Anton Paier and 
Aivar Liiv) and observed aberrant subunits also in both of our toxin induction 
experiments (publication II; Figure 4B). Northern blot analysis showed that the 
irregular particles contained the majority of fragmented RNA (publication II; 
Figure 4C). In an MqsR expression culture we also saw the accumulation of 
16S rRNA precursors in aberrant subunits (publication II; Figure S11A). The 
rRNA fragmentation patterns matched with the corresponding toxin fragmenta-
tion patterns in total RNA, thus indicating that we see toxin cleavage and not 
artefacts of gradient preparation. The heavy fragmentation of aberrant subunits 
implies that the defects might result from toxin cleaved precursor rRNA that 
cannot be packed into normal subunits. 
We also tested whether RNA from 70S contains any toxin cleavage sites 
using more sensitive techniques. We failed to see 5’ ends at major toxin 
cleavage sites using primer extension (publication II; Figure S12, Figure S13), 
but did detect MazF cleavage in 16S rRNA using 3’-RACE and northern blot 
hybridization from 6% PAGE in 7M urea (publication II; Figure 5). 3’-RACE 
identified MazF generated 3’ ends at MazF cleavage sites in positions ˇ1394ACA 
and ˇ1396ACA (publication II; Figure 5A, Figure S14B). The fragments detected 
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by northern blot analysis correspond to downstream cleavage products of these 
positions in both mature and precursor 16S rRNA. We propose that the frag-
ment originates from unprocessed rRNA because we also detected precursor 
rRNAs in the 70S fraction. Primer extension allowed us to identify 5’ ends of 
23S precursor in MazF and MqsR expression cultures (publication II; Figure 
S11B) and 3’ RACE revealed the 3’ end of 16S precursor in MazF expression 
culture (publication II; Figure 5A, Figure S14A). The final steps of rRNA 
processing occur in translating ribosomes and are not required for the formation 
of 70S ribosomes [186–188], so one can expect to find precursor rRNAs in the 
70S fraction.  
We did not detect 16S 3’ ends that correspond to cleavage at ˇ1500ACA in the 
70S fraction in MazF expression culture, which, again, might be due to heavy 
methylation of the region. On the other hand, these ends should be detectable in 
precursor rRNA of total RNA samples. Their absence leads us to believe that 
this cleavage is rare, at least in precursors, and only a sensitive northern blot can 
detect its products. We did not see the 43 nucleotide fragment that migrates 
together with the 70S ribosome fraction as was previously reported (publication 
II; Figure 5B). Thus, our experiments do not provide evidence for the proposed 
MazF generated stress ribosome hypothesis. 
 Since the release of our paper, Culviner and Laub have published another 
study that tackles the issue of MazF generated stress ribosomes and rRNA 
cleavage by MazF [69]. They detected very little 43 nucleotide fragments of the 
16S 3’ end after an hour-long MazF production period [69]. Also, they 
demonstrated that MazF only cleaves freshly synthesized rRNA by using pulse 
labelling experiments [69]. Thus, their data agrees with our result that MazF 
does not generate specialized stress ribosomes.  
This work reminds one of the importance of employing diverse techniques 
while studying rRNA cleavage because not all rRNA fragments originate from 
correctly processed and packed mature ribosomes. Our data indicate that, in 
addition to mRNA, MazF and MqsR also extensively cleave precursor rRNAs. 
This could halt ribosome biogenesis under stressful conditions where toxins are 
speculated to be active (Figure 4). Rapid ribosome synthesis under harsh 
conditions would be a waste of resources and endoribonuclease toxins could be 
one of the mechanisms that help to shut it down. Cleaved and then processed 
rRNA fragments can be utilized elsewhere. Alternatively, the degradation of 
rRNA precursors is yet another way to inhibit growth. Either way, downscaling 
translational machinery seems be one of the main roles of MazF and MqsR 
toxins. 
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Figure 4. Our model of MazF and MqsR activity. MazF and MqsR degrade un-
structured RNA, like mRNA and rRNA precursors, but cannot attack highly structured 
mature ribosomes. MazF does not generate specialised ribosomes. Red lines ending 
with arrow heads show molecular targets of MazF and MqsR, and red lines with blunt 
ends show molecular processes inhibited by MazF and MqsR. aSD means anti-Shine-
Dalgarno sequence. 
 
 
3.5. Expressing MazF and MqsR leads  
to major changes in the transcriptome 
During various stresses, MazF is hypothesized to generate a pool of 330 tran-
scripts (the co-called MazF regulon) cleaved only in 5’ UTR, which are speci-
fically translated by the MazF-generated stress ribosomes. By this model, MazF 
would shut down the translation of the majority of the genes, while promoting 
the translation of some essential stress-related genes [2]. Regardless of the 
existence of MazF-generated stress ribosomes, the reported pool of 330 MazF-
truncated stress specific transcripts offers an intriguing opportunity for biased 
translation during stress. This contradicts with the initial hypothesis, which sees 
MazF acting only as a growth inhibitor that cleaves unstructured mRNA [67]. 
How the transcripts of the MazF regulon are protected from cleavage in the 
coding region has not been explicitly made clear, but authors who described the 
MazF regulon seem to imply that cleavage sites become masked by the 
translating stress ribosomes [189]. To test whether MazF cleaves mRNAs 
selectively or without bias we analysed differential and random primed RNA 
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sequencing data obtained from E. coli cultures where MazF was overexpressed 
for two hours. In addition, we studied mRNA cleavage in response to MqsR 
expression, to analyse if another endoribonuclease toxin can also generate a 
toxin-specific set of truncated mRNAs. 
The random primed paired-end RNA sequencing libraries we used for 
mapping the cleavage sites also contain information about relative transcript 
levels. Thus, we first studied whether the expression of MazF or MqsR results 
in transcriptional upregulation of a specific set of stress response genes, e.g. the 
hypothesized MazF regulon. cDNA libraries were again prepared and se-
quenced by Vertis Biotechnologie AG. These cDNA libraries were originally 
designed for detecting ligation of different toxin cleaved fragments by RNA 
ligase RtcB and thus they are composed of reads with abnormal, 300 nucleotide, 
length. Despite that, the libraries were applicable for transcript level determi-
nation. Overexpression of MazF or MqsR both led to major changes in relative 
transcript levels (publication III; Figure 1A). Significant shifts in mRNA 
abundance have also been previously described in short term MazF expression 
experiments [2,190]. Many stress response genes, e.g. rpoS, ada, and the psp 
operon, displayed an increase in transcript levels while ribosomal protein and 
flagellar genes showed a reduction (publication III; Figure 1A). This is in line 
with previous reports that show that MqsR induction reduces the transcript 
levels of motility and ribosomal protein genes [191]. The transcript levels of the 
proposed MazF regulon genes did not have a directional shift in MazF expres-
sion culture (publication III; Figure 1D). Thus, these genes do not seem to be 
induced at the transcriptional level. 
We verified increased transcriptional expression levels in toxin cultures for 
rpoS, relE/hokD, higA and decreased levels for rpmB and ptsH using RT-qPCR 
(publication III; Figure S3). Because toxins alter the transcriptional levels of 
most genes, we used a spike-in culture of Pseudomonas aeruginosa PAO1 as a 
source for reference transcripts (oprL, cheZ, and PA3340). The spike-in culture 
also allowed us to normalize the RNA content to the biomass. We expected that 
a two hour toxin production regime would significantly reduce the total mRNA 
levels, however, to our surprise, the amount of mRNA remained the same. 
Normal RNA levels in bacterial cultures where endoribonuclease toxins are 
overexpressed could be explained by a recent study by the Brynildsens group. 
They describe futile cycling of RNA in MazF expression cultures where energy 
is being depleted due to continuous RNA synthesis [192]. They hypothesize that 
an end product is rarely produced from mRNAs due to constant degradation by 
MazF. This leads to a deficiency in transcriptional regulators, which in turn 
results in uncontrolled transcription that lasts until the cells are depleted of 
energy. Broken feedback loops that drive this futile cycle could explain why the 
RNA levels remain the same in our toxin expression experiments. 
Transcript levels do not necessarily measure the promoter activity under 
conditions where endoribonucleases are overexpressed: transcript level values 
could represent a graveyard of old RNA cleavage fragments. We wanted to 
know how well the promoter activities correlate with transcript levels after two 
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hours of toxin overproduction. The primary transcripts are short-lived (around  
3 min half-life on average) [193], and detecting them in our toxin-affected sample 
would equate to freshly synthesized RNA. We used differential sequencing of 5’-
PPP ends to assess the synthesis of new RNA. Its principle is the same as for 
detecting MazF and MqsR cleavage sites: the adapter can be only ligated to the 
5’-P ends of fragments, and 5’-PPP ends need to be converted to 5’-P ends using 
tobacco acid pyrophosphatase to be detectable during sequencing. Comparing the 
5’ end counts per position between treated and untreated libraries revealed 
transcriptional start sites. We detected 1228 transcriptional start sites of which 
964 are within five nucleotides of a previously described E. coli transcriptional 
start site (publication III; Figure 1B, Table S5) [194]. The majority of these sites 
appeared in MazF and MqsR expression cultures. 
The primary transcript abundancies poorly correlate with transcript levels 
(the r2 for MqsR was 0.45 and the r2 for MazF was 0.17), which can be ex-
plained by extensive RNA fragmentation (publication III; Figure 1C). Cleavage 
near the 5’ ends of transcripts renders them undetectable in differential se-
quencing because of the 100 nucleotide read length. Also, upstream cleavage 
fragments are unstable in general due to the action of 3’-to-5’ exoribonucleases 
within E. coli and are degraded more rapidly. High transcript levels can still be 
detected when downstream fragments remain stable because relative RNA level 
quantifying methods, such as the TPM (Transcripts Per Kilobase Million) 
method we used [195], calculate transcript abundances based on the number of 
reads mapped against ORF. Indeed, inspecting read count density profiles 
revealed the accumulation of downstream cleavage fragments (selected examp-
les in publication III; Figure 2). yjdM is a good example of the discrepancy 
between TPM and primary transcript levels in toxin expression cultures. The 
yjdM transcript is cleaved near the 5’ end by MazF and MqsR (publication III; 
Figure 2C) and shows decreased primary transcript levels following toxin 
expression (data not shown). Transcript levels, on the other hand, remain stable. 
In conclusion, interpreting RNA sequencing data of endoribonuclease expres-
sion experiments is not straightforward. Usually, changes in mRNA levels are 
expected to cause matching changes in protein expression. However, due to 
extensive mRNA cleavage and broken feedback loops, changes in mRNA 
quantity do not lead to corresponding changes in protein levels. We showed that 
almost all translational activity is arrested during MazF expression using mass 
spectrometry (discussed in chapter 3.9). 
 
 
3.6. mRNA cleavage by MazF and MqsR 
We used the accumulating 5’ ends of MazF- or MqsR-generated RNA frag-
ments to map corresponding toxin cleavage sites across the entire transcriptome. 
Both our differential and random primed paired-end sequencing libraries could 
be used to identify cleavage sites in mRNAs. Despite the fact that our 
differential sequencing libraries were designed to detect rRNA cleavage, plenty 
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of reads (120 000 – 330 000 reads per library) mapped outside of rRNA operons 
and we used these to find mRNA cleavage sites (publication III; Table S2). 
Lower read counts made us change the cleavage site parameters to allow for 
cleavage site identification in weakly expressed transcripts. We calculated 5’-
OH/5’-P end ratios across the entire transcriptome and excluded genomic 
positions where the ratio was below five in toxin expression culture. Next, we 
searched for sites with enriched 5’-OH/5’-P end ratios in toxin culture (5’-
OH/5’-P end ratio in toxin culture had to be five times higher than in control). 
95% of the positions detected this way mapped to corresponding toxin recogni-
tion sequence and we consider these to be cleavage sites. 
The random primed paired-end sequencing library fragments were generated 
by sonication, which disrupts RNA at random sites. We noticed the accumu-
lation of 5’ read stacks while looking at coverage profiles of toxin expression 
culture (selected examples in publication III; Figure 2). Closer investigation 
revealed that many of these 5’ end stacks map to a toxin recognition sequence 
and are likely not artefacts of sonication, but represent stable toxin cleavage 
products. 90% of the 5’-end stacks that were present in MazF culture but absent 
in the control experiment appeared at toxin recognition sequences. We regard 
these positions as MazF cleavage sites. For MqsR, only 50% of the toxin culture 
specific 5’-end stacks mapped to recognition sequences. We considered this 
ratio to be too low and mapped MqsR cleavage sites using only differential 
sequencing. 
For both of our sequencing approaches we used RNA from bacterial cultures 
with rather long two hour toxin expression times. This allowed for the accumu-
lation of stable cleavage fragments and increased the probability of detecting 
cleavage sites in transcripts with low expression levels. 
Both MazF and MqsR extensively cleave mRNAs, with MazF cleavage 
detected in 56% and MqsR cleavage in 30% of open reading frames (publica-
tion III; Table 1, Table S3, Data Set S1). MazF attacked 13.4% (publication III; 
Table 2) and MqsR 1.5% (publication III; Table S4) of all possible recognition 
sequences located in the ORFs. These toxins likely target many more transcripts 
and cleavage sites because genes with very low expression levels under these 
conditions were undetectable. We did indeed see a bias towards identifying 
cleavage sites in highly expressed genes (publication III; Figure 3A, B). Also, 
the 100 and 300 nucleotide long reads used in our experiment limit the detection 
of shorter cleavage fragments. Sequencing experiments with higher read counts 
and shorter reads are required to reveal all potential MazF and MqsR cleavage 
sites. In addition, we determined MazF cleavage sites in E. coli culture that had 
been recovering from toxin expression for 30 min. Because we did not subject 
the recovery culture to differential sequencing, our cleavage site analysis is 
based only on random primed paired-end data. We see that the mRNA in 
30 min regrowth culture is still highly fragmented (publication III; Table S3), 
which indicates that the cells have not yet recovered from the toxin damage. 
Random primed libraries allow us to assess the cleavage depth by comparing 
the 5’ end stacks of fragments that map to cleavage sites to the total coverage at 
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that position. We note that different stabilities of the cleavage fragments distort 
this analysis. Still, it is fairly safe to assume that if the 5’ end count of a position 
exceeds the number of overlapping reads, the position is effectively being 
cleaved. Many highly expressed transcripts have several strong and/or dozens of 
weaker cleavage sites. For example, MazF cleaves the vast majority of relE 
transcripts at a single site (publication III; Figure 2A) and MqsR cleaves fusA at 
41 positions (publication III; Data Set S1). These transcripts are likely not 
translated into proteins. We conclude that an increase in TPM levels during 
endoribonuclease toxin expression does not necessarily equate to increased 
protein production or higher levels of functional ncRNAs. High transcript levels 
are often the result of accumulating cleavage fragments. The transcript level 
profile we observe is a mixture of newly synthesized RNA and cleavage frag-
ments awaiting cleanup. 
We used primer extension to verify major MazF cleavage sites in relE, rpsA, 
lon, and higA transcripts and the MqsR cleavage site in rpmC transcript 
(publication III; Figure S4). In the study, which identified the MazF regulon, the 
toxin was expressed for only 15 min, which is considerably shorter than our two 
hour experiment. We checked whether the cleavage in lon, rpsA, and relE 
transcripts also persists using shorter MazF induction times (publication III; 
Figure S5). rpsA and lon ORF-s were both cleaved after 10 min of MazF 
expression. Primer extension was not able to detect cleavage in relE after either 
10 or 20 min of MazF expression. Still, we saw massive relBEF fragmentation 
in 15 min MazF expression culture using northern blot analysis (publication I; 
Figure 1). relBEF transcript levels seem to be too low in short-term MazF 
expression cultures to be detectable with primer extension. 
Massive cleavage site data allowed us to elaborate on the preferred recogni-
tion sequences of MazF and MqsR. Culviner and Laub propose that MazF of E. 
coli favours a seven nucleotide cleavage sequence, where ACA is at the center 
[69]. This is in line with a recently resolved structure showing that MazF 
interacts with the upstream and downstream nucleotide around ACA; all of the 
nucleotides need to be unpaired for MazF to bind [70]. We observed a slight 
context bias only at the flanking nucleotides: C is underrepresented at the up-
stream and G at the downstream position, while A is the most frequent 
nucleotide at both of these positons (publication III; Figure 3C). The discrepan-
cies between our sequence logos can be explained by the different set of 
cleavage sites and nucleotide probabilities at surrounding positions. We used an 
equiprobable background while Culviner and Laub used the nucleotide bias 
surrounding all ACA sites in the coding region. As reported previously, MqsR 
preferentially cleaves at GˇCU (publication III; Figure 3C, Table S4). GˇCC 
was the second most abundant recognition sequence and GˇCA the third, and 
cleavage at GˇCG occurred rarely. 
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3.7. The proposed MazF regulon genes are cleaved in  
the coding sequence 
We looked for 5’ truncated mRNAs in MazF expression culture using the same 
parameters as the authors who reported the MazF regulon: 5’ UTR was defined 
as the area of 101 nucleotides upstream of the start codon and any overlap with 
preceding genes was ignored. Cleavage in the proposed MazF regulon was 
significantly overrepresented with as 58% of the transcripts of the putative 
regulon were truncated in 5’ UTR compared with only 16% of all genes (publi-
cation III; Table 1). However, most of the MazF regulon mRNAs were also 
cleaved in ORF. The authors of the original publication focused only on 5’ UTR 
cleavage and missed strong cleavage sites inside the ORFs [2]. We see another 
set of transcripts cleaved only in the 5’ UTR, which is composed of 40 of the 
proposed MazF regulon transcripts and 123 other transcripts. Theoretically, this 
set of transcripts could form an alternative MazF regulon, seen only under our 
tested conditions. We find this speculation to be highly unlikely because of the 
163 transcripts where we detected cleavage sites only in 5’ UTR do not show 
any statistically significant functional enrichment. The alternative MazF regulon 
is a collection of shorter transcripts for which our technical limitations (long 
reads) prevent the detection of in-gene cleavage sites (data not shown). In 
addition, shorter transcripts contain fewer ACA sites, so selection of smaller 
mRNAs while searching for uncleaved transcripts is to be expected. MqsR 
cleaved 48 mRNAs only in 5’ UTR. Most of these transcripts did not belong to 
the proposed MazF regulon nor were they a part of the 163 genes cleaved in 
only 5’ UTR by MazF. As with MazF, the MqsR-generated transcript pool, for 
which we see cleavage only in 5’ UTR, contains mainly short mRNAs (data not 
shown). 
Culviner and Laub also studied the cleavage of mRNAs in response to MazF 
expression and published their results a few months before us [69]. Their RNA 
sequencing experiments revealed 41 transcripts that were cleaved in 5’ UTR, 
but most of these also contained cleavage in ORF [69]. Thus, their data agrees 
with our results. 
One could argue that we unfairly disregarded the MazF regulon by looking 
purely at the number of cleavage sites. Abundant translatable 5’ truncated 
mRNAs can still exist if the cleavage in ORF is minor and in 5’ UTR extensive. 
The MazF regulon transcripts have on average deeper 5’ UTR cleavage sites 
than the rest of the transcriptome, however, coding sequences in both groups are 
cleaved to a similar degree (publication III; Figure S6A, B). Therefore, most of 
the MazF regulon transcripts are unlikely to be translated into complete pro-
teins. 
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3.8. MazF regulon is cleaved by MazF without  
reading frame bias 
Authors of the MazF regulon hypothesis propose that MazF binds to truncated 
ribosomes and performs frame-dependent quality checks [189]. Stress ribosome 
bound MazF is hypothesized to only cleave in-frame ACA sites, thus generating 
pressure to remove this codon from the MazF regulon. This mechanism would 
benefit the cell by excluding frame shifts while translating essential stress genes 
under harmful conditions. The authors base their hypothesis on a few MazF 
regulon genes without in-frame ACA sites, and GFP mutant reporters that 
produce a weaker signal after insertion of in-frame ACA sites. We studied the 
plausibility of frame specific cleavage using our transcriptome-wide cleavage 
data. We see abundant out of frame cleavage in MazF regulon transcripts and in 
the rest of the transcriptome (publication III; Table 2). MazF targets a larger 
percentage of ACA triplets, both in and out of frame, in the proposed MazF 
regulon compared with the rest of the transcriptome. We separately checked for 
out of frame cleavage in the seven genes (efp, deoC, soxS, rbfA, ahpC, rpsA, 
and groEL) used as examples of in-frame ACA deficit. mRNAs of six of them 
have out of frame cleavage in our analysis which implies that MazF does not 
facilitate their expression. 
Isabella Moll’s group also proposed that Thr codon usage is altered in the 
MazF regulon due to a lack of in-frame ACA. We analysed the Thr codon usage 
of the proposed MazF regulon and over the entire genome. The ACA/all Thr 
codon ratio is slightly lower in the proposed MazF regulon (0.09) compared 
with the entire genome (0.13; publication III; Table S8). The hypothethical 
MazF regulon also has a higher share of ORFs that lack in-frame ACA triplets 
(31%) than the rest of the genome (23%; publication III; Table S7). Neverthe-
less, we consider these differences too small to support MazF-driven codon 
bias. Alternatively, MazF could drive the codon usage of the entire genome, as 
bacteria try to minimize the damage done by toxins and ensure post-stress 
regrowth. Although this hypothesis is highly speculative, we decided to test it. 
We compared ACA to all Thr codon ratios of various E. coli and Shigella 
strains, some of which did not have the mazEF TA system, and observed similar 
ACA codon usage in all the bacteria we analysed (publication III; Table S7). 
We conclude that MazF can cleave all unstructured and unprotected ACA sites 
independently of the reading frame. 
 
 
3.9. MazF regulon is not preferentially translated during 
MazF induction 
The best way to confirm or refute the MazF regulon is to directly measure the 
protein production of MazF expressing cells. A previous study reported low 
levels of translation in MazF expression culture using [35S]methionine in-
corporation [67]. The proposed MazF regulon genes may represent the majority 
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of newly synthesized proteins. We used SILAC (stable isotope labeling with 
amino acids in cell culture) to analyse the proteome of E. coli MazF expression 
culture [196]. E. coli was pre-grown in “light” medium and switched to “heavy” 
medium upon induction of MazF synthesis from a plasmid. Glucose was the 
carbon source during pre-growth, L-arabinose was both the carbon source and 
inductor for MazF synthesis during the toxin expression phase of the experi-
ment. Proteins were quantified using mass spectrometry. The mass spectrometry 
work was performed by Merilin Saarma and Sergo Kasvandik. Comparing the 
heavy/light ratios of proteins provides the relative amount of new proteins that 
are produced during the expression of the toxin. 409 proteins were identified in 
all three replicates of MazF expression cultures and 1035 in three replicates of 
an empty expression vector control (publication III; Data Set S4). This implies 
that the synthesis of hundreds of proteins was arrested in response to MazF 
expression. The vast majority of the proteins we managed to detect following 
MazF induction have very low heavy/light ratios at the 20 min time point, and 
reveal only a marginal increase at the 60 min time point (publication III; Figure 
4). The heavy/light ratios of the control culture increase significantly between 
the 20 min and 60 min time points and the heavy/light ratios at 20 min are much 
higher than for MazF. Taken together, this data indicates that translation is 
halted for almost all genes during MazF overexpression. 
We detected 71 proteins that belong to the hypothetical MazF regulon. Their 
expression profiles in MazF induction and control cultures were the same as for 
the rest of the proteins (publication III; Figure 4), thus refuting the hypothesis 
that the translation of this group of proteins is selectively promoted by MazF. 
Also, SILAC revealed only eight proteins encoded by transcripts for which we 
saw cleavage only in 5’ UTR, and seven of these had low heavy/light ratios. We 
conclude that under our experimental conditions neither of the MazF regulons 
exists. Culviner and Laub [69] also report a general arrest of translation during 
the expression of MazF based on reduced ribosome densities at the 3’ ends of 
the transcripts. Also, their ribosome profiling experiments did not reveal in-
creased translation of transcripts with truncated 5’ UTR.  
We identified only a handful of proteins whose production remained unin-
hibited in MazF-expressing bacteria (publication III; Table S9). The heavy/light 
ratio of eight proteins increased at least two fold between 20 min and 60 min 
time points. Seven of these had a low heavy/light ratio after 60 min of MazF 
production, thus indicating a slow translation rate. One protein, AraC, reached a 
heavy/light ratio of two at the 60 min time point. This result is not surprising 
because AraC is upregulated in response to our inductor and carbon source L-
arabinose. AraC controls the expression of genes involved in L-arabinose meta-
bolism [197]. Three other proteins – MazF, IraP, and UspF – had a heavy/light 
ratio above two at the 60 min time point, but this ratio was also the same at the 
20 min time point (publication III; Figure 4A). A high level of the over-
expressed MazF is to be expected. The two other proteins are involved in stress 
response: UspF promotes adhesion and IraP stabilizes alternative sigma factor 
σS [198,199]. Genes that encode these proteins contain very few ACA sites, 
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uspF has two ACA sites and iraP has only one ACA site, which could partially 
explain their tolerance to MazF cleavage. As expected, we did not detect any 
cleavage at their ACA sites. It is possible that these sites are located in double-
stranded regions of mRNA.  
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4. CONCLUSIONS 
Our data do not support the existence of specialised MazF-generated translatio-
nal machinery. We show that the MazF and MqsR toxins of E. coli act as 
degraders of unstructured RNA. The endoribonuclease toxins of E. coli are 
usually thought to arrest growth through mRNA cleavage, however, our results 
suggest that extensive cleavage of rRNA precursors also contributes to growth 
inhibition (Figure 4). 
The most important results of our work are: 
 The MazF and MqsR toxins of E. coli primarily act as degraders of un-
structured RNA (publication III). 
 The MazF and MqsR toxins of E. coli extensively cleave precursor 
rRNAs, but cannot attack rRNA in mature ribosomes (publication II). 
 Expression of MazF strongly impairs the production of the majority of 
proteins (publication III). 
 The 3’ end of 16S rRNA is not cleaved by MazF in mature ribosomes and 
does not lead to the generation of specialised ribosomes (publication II). 
 Most transcripts that belong to the hypothetical MazF regulon are cleaved 
in ORF and none of the transcripts are specifically translated during 
MazF expression (publication III).  
 There is no bias against the ACA codon in the hypothetical MazF regulon 
(publication II and III). 
 All cells in a culture of Escherichia coli recover from 90 min of MazF, 
MqsR, RelE, or HipA production. The recovery of a subpopulation of 
bacteria is delayed after the expression of MazF and MqsR (publication I). 
 Toxins can activate the transcription of non-cognate toxin-antitoxin 
systems and relBEF is required for the transcriptional activation of 
mazEF during amino acid starvation (publication I, III). 
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SUMMARY IN ESTONIAN 
Escherichia coli RNA fragmenteerimine MazF ning  
MqsR toksiinide poolt 
Bakterite toksiin-antitoksiin süsteemid on väikesed geneetilised moodulid, mis 
kodeerivad toksilist valku ja seda neutraliseerivat antitoksiini. Antitoksiini 
taseme langedes inhibeerib toksiin teda tootva raku kasvu. Esialgselt avastati 
toksiin-antitoksiin süsteemid plasmiididelt kui neid stabiliseerivad üksused. 
Toksiinid on võrreldes antitoksiiniga stabiilsemad ning säilivad plasmiidi kao-
tuse korral rakus palju kauem. Seetõttu on plasmiidi kaotanud bakterite kasv 
pärsitud ja kasvueelise saavad plasmiidi pärinud rakud. Peatselt avastati, et 
toksiin-antitoksiin süsteemid on laialt levinud ka kromosomaalses DNA-s. 
Vaatamata laialdastele uuringutele ei ole kromosomaalsete toksiin-antitoksiin 
süsteemide roll veel üheselt selge. Osad hüpoteesid näevad kromosomaalseid 
toksiin-antitoksiin süsteeme ainult liikuvate geneetiliste üksuste integreerumise 
ülejääkidena. Samas seostavad mitmed uuringud neid bakteriofaagide vastase 
kaitse, stressivastuse, antibiootikumidele tolerantsuse ja bakterite virulentsu-
sega. Toksiin-antitoksiin süsteemide uurimine võib seetõttu aidata meil pare-
mini mõista bakteriaalseid infektsioone ja pakkuda uusi lahendusi nendega 
toime tulekuks. 
Toksiinid ründavad erinevaid rakulisi protsesse nagu translatsioon, replikat-
sioon ja energia tootmine. Seejuures on RNA lõikamine ülekaalukalt kõige levi-
num toksiinide toimemehhanism. Toksiinid lagundavad RNA-d kas ribosoomi-
dega seondunult või iseseisvalt. Ribosoomist sõltumatud ribonukleaassed tok-
siinid lõikavad tavaliselt kindlat RNA järjestust, näiteks Escherichia coli MazF 
toksiin tunneb ära ACA ja E. coli MqsR toksiin GCU järjestuse. Klassikaliselt 
on ribonukleaasseid toksiine peetud mittespetsiifilisteks mRNA lagundajateks, 
mis halvavad raku kasvu rünnates enamikke valku kodeerivatest transkriptidest. 
Hiljutised uuringud näitasid, et osad MazF ja VapC perekonna toksiinidest 
inhibeerivad translatisooni ka rRNA-d või tRNA-d lõigates. Escherichia coli 
MazF toksiini puhul on näidatud 16S rRNA lõikamist, kuid väidetavalt ei ole 
selle eesmärgiks translatsiooni inhibeerimine, vaid selle ümberprogrammee-
rimine. Nende uuringute kohaselt lõikab E. coli MazF stressi tingimustes küp-
sete ribosoomide 16S rRNA 3’ otsast ära 43 nukleotiidi pikkuse fragmendi. 
Arvatakse, et selliselt kärbitud ribosoomid toodavad valke 5’ otsast kärbitud 
spetsiifilistelt mRNA-delt. Spekuleeritakse, et MazF lagundab enamiku mRNA-
dest, kuid tekitab ka kärbitud 5’ otstega stressivastuse geenide mRNA-de alam-
hulga – MazF reguloni. Sedasi aitaks MazF stressi korral raku kasvu aeglustada 
ja samas tagaks oluliste stressigeenide avaldumise. 
Meie tuvastasime E. coli MazF ja MqsR toksiinide üleekspressiooni katsetes 
pikkade rRNA fragmentide teket ning otsustasime lähemalt uurida nende 
toksiinide rolli rRNA lõikamisel. Me kaardistasime MazFi ja MqsRi lõikekohad 
rRNAs. Selleks kasutasime spetsiaalset RNA sekveneerimist, mis suudab vahet 
teha toksiinide ja rakuliste ribonukleaaside poolt tekitatud RNA otstel. Kaardis-
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tatud lõikekohad 16S ja 23S RNAs ei ole küpsetes ribosoomides toksiinide 
poolt lõigatavad: nad asuvad kas sügaval alaühiku sees või rRNA kaheahela-
listes piirkondade. Kõik meie andmed viitavad sellele, et toksiinid lõikavad 
protsessimata rRNA-d, mitte küpseid ribosoomi alaühikuid. Eellas-rRNA lagun-
damine välistab uute ribosoomide tootmise ja suunab ressursse ümber raku 
muudeks vajadusteks. 
Lisaks uurisime mRNA lõikamist MazF ja MqsR poolt, et jõuda selgusele, 
kas spetsiifiline 5’ kärbitud stressi-mRNA-de grupp eksisteerib või mitte. Kasu-
tasime toksiini üleekspresseerimist ja sellele järgnevat RNA sekveneerimist, et 
kaardistada toksiinide lõikekohad mRNAs. Mõlemad toksiinid lõikasid ulatusli-
kult mRNAsid: MazF lõikas pooli ja MqsRi ühte kolmandikku avatud lugemis-
raamidest. Leidsime, et enamikke niinimetatud MazF reguloni transkriptidest 
lõigati MazF-i poolt efektiivselt ka avatud lugemisraamis. Meie tulemuste 
kohaselt lõikavad need kaks toksiini mRNA tükikesteks, millest järeldame, et 
mingit MazF reguloni pole olemas. Ka proteoomika tulemused kinnitasid, et nn. 
stressivalke, mille tootmist MazF peaks soodustama, tegelikult MazFi ekspres-
siooni tingimustes ei toodeta. 
Kokkuvõtteks, meie andmed ei toeta hüpoteesi, mille kohaselt põhjustab 
MazF toksiin translatsiooni ümberprogrammeerimise. Meie tulemused näitavad, 
et MazF ja MqsR on mittespetsiifilised RNaasid, mis lõikavad kõike kätte-
saadavat struktureerimata RNA-d. Järeldame, et nende toksiinide funktsioon on 
raku kasvu peatamine läbi uute valkude ja ribosoomide sünteesi inhibeerimise. 
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